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INTRODUCTION 
This study examines the effect of two human DNA viruses 
on primary human cells. Herpes simplex virus 2 (HSV-2) and 
either human papillo~avirus type 16 or type 18 (HPV-16, HPV-
18) DNA was intrGduced into human cells to generate 
transformed cell lines. Cell lines were established with two 
human cell types: keratinocytes, the naturally infected cell 
in vivo by HPVs and HSV-2, and fibroblasts. Although 
fibroblasts are not the target cell of HPVs, they were 
utilized because of the availability of two cell strains: 
normal primary gingival fibroblasts (N-16) and a hyperplastic 
counterpart (R-30). It has been hypothesized that 
transformation is a multistep phenomenon (reviewed in Bishop, 
1985) . The primary aim of this investigation was to determine 
if HSV-2 and HPV-16/18 cooperate to morphologically transform 
primary human cells. 
Transfection of primary cells with HPV types 16 or 18 DNA 
alone produces an immortalized cell. These cells do not 
produce tumors when heterotransplanted into immunosuppressed 
mice (Durst et al., 1987, Pirisi et al., 1987) suggesting 
progression to the malignant phenotype after HPV infection in 
vivo requires additional cofactors. HSV-2 is hypothesized to 
1 
2 
cooperate with oncogenic HPVs to produce a malignant phenotype 
{zur Hausen, 1982). Keratinocyte or fibroblast HPV 
immortalized cell lines were compared with respective 
HPV/HSV-2 transformed cell lines in four major areas of study. 
The first area examined was growth characteristics. 
saturation density analysis and anchorage independent growth 
studies demonstrated that transformed cells proliferated more 
' 
efficiently 
counterparts. 
than. their corresponding immortalized 
The second area of study was to determine if viral DNA 
was retained in the various cell lines. HPV sequences are 
present in 80-85% of cervical carcinoma biopsies {Broker and 
Botchan, 1986, Durst et al., 1983) and are usually integrated 
into the cellular genome with only a portion of the viral DNA 
present {Durst et al., 1985). Transformed cell lines were 
analyzed by Southern blot analysis to determine retention and 
genomic organization of HPV DNA as well as to study the 
physical state of HPV DNA. Retention of HSV-2 DNA sequences 
in transformed cells was examined by polymerase chain reaction 
{PCR) analysis. Approximately 50% of the cell lines retained 
HSV-2 DNA sequences. Comparison of HPV immortalized 
keratinocytes with HPV-18/HSV-2 transformed keratinocytes 
showed rearrangement of HPV DNA in the transformed cells in 
contrast to the immortalized cell lines. 
Integration of HPV-16 DNA into the cellular genome has 
been shown to cause alterations of the c-myc protooncogene 
3 
(Rieu et al., 1987, Durst et al., 1987, Crook et al., 1990) 
and organization of this gene in transformed cell lines was 
analyzed. Interactions of the tumor suppressor gene, p53, and 
subsequent inactivation of this gene are associated with high 
risk HPVs such as type 16 and 18 (Werness et al., 1990, 
scheffner et al., 1990). To understand what role this 
cellular protooncoge~e and tumor suppressor gene have in the 
morphological transf-0rmation of primary human cells was the 
third aim of this study. 
The final area of analysis was to examine the tumorigenic 
potential of the immortalized and transformed cell lines. 
Nude mice were injected subcutaneously with different cell 
lines and examined for the production of palpable tumors. 
LITERATURE REVIEW 
Multistep phenomenon of transformation. Morphological 
transformation of primary cells is a multistep phenomenon 
(reviewed in Bishop, ,1985, Stanbridge, 1990). Many mechanisms 
exist in the etiology of human malignancy, however, it is not 
known what specific factors are required for progression. 
Malignant tumors are thought to result from a series of events 
which are cumulative with each subsequent event generating an 
additional phenotypic alteration. Genetic aberrations, due to 
endogenous or exogenous stimulation, which extend cellular 
lifespan, can allow for overall genetic instability within 
these cells (Meuth, 1990). 
several factors are associated with instability leading 
to progression. Loss or gain of entire chromosomes can lead 
to severe aneuploidy (German, 1983), a common characteristic 
of cancer cells. Large scale deletions within chromosomes 
(Vogelstein et al., 1989) can also lead to loss or 
rearrangment of regulatory genes resulting in an increased 
risk of mutation or gene amplification (reviewed in Meuth, 
1990, Giulotto et al., 1987). A specific order of events is 
not required, rather the summation of these events is 
hypothesized to be the primary factor in carcinogenesis 
4 
5 
(reviewed in Bishop, 1991). 
Environmental and chemical mutagens, viral oncoproteins 
and hereditary factors are associated with carcinogenesis. 
several viruses have recently been correlated to the etiology 
of human tumors: 1) hepatitis B virus associated with cancer 
of the liver (Wang et al., 1990), 2) Epstein-Barr virus 
associated with Burkitt's 
1 
lymphoma and nasopharyangeal 
carcinomas (Raab-Traub et al., 1983, Fahreus et al., 1988), 3) 
human papillomaviruses and 4) herpes simplex virus 2 
associated with genital carcinomas (Rawls et al., 1969, DiLuca 
et al., 1989). 
Cancer of the cervix is the second leading cancer in 
women (Parkin et al., 1988). Epidemiological studies of 
precancerous lesions and invasive cervical carcinomas have 
demonstrated a correlation between these lesions and sexually 
transmitted disease (STD). The major risk factors of cervical 
carcinoma are the early age of intercourse and multiple sexual 
partners (Rotkin, 1973, Kessler, 1977). The prevalence of 
viral and viral-associated antigens as well as viral nucleic 
acid in many anogenital lesions associated with STD has 
suggested human papillomaviruses (HPVs) are the etiological 
agents of many of these STD lesions (Becker et al., 1987). 
With approximately one sixth of all cancer deaths in females 
due to cervical cancer, there is significant interest in 
understanding the pathogenesis of HPVs in genital cancer 
(Parkin et al., 1988). 
6 
Classification of PVs. The papillomaviruses (PVs) are a 
group of small DNA viruses in the Papovaviridae (Ginsberg, 
1980). They typically induce proliferative lesions of the 
skin and mucosal epithelia. PV infections are widespread in 
mammals affecting cattle, sheep, deer, dogs, monkeys, pigs or 
man (Sundberg, 1987). Classification is based on host range 
with type categorization based on nucleic acid hybridization 
1 
studies. Viral isolates are considered an independent type if 
there is less than 50% homology with known isolates (Coggin 
and zur Hausen, 1979). 
PVs are the etiological agents of many epithelial 
disorders. Specific PV types are associated with specific 
disease processes ranging from warts to human cervical 
carcinoma. Oncogenic activity of PVs was first described in 
rabbits where cottontail rabbit papillomavirus (CRPV) induced 
benign papillomas which later metastisized to lymph nodes and 
lungs (Rous and Beard, 1935). Over 6 O types of human 
papillomaviruses (HPV) have been identified. Each HPV type 
has site preferences for either cutaneous or mucosal squamous 
epithelium where many can cause clinical lesions (Jenson et 
al., 1988). Benign proliferative lesions of cutaneous 
epithelium are referred to as warts whereas mucosal lesions 
are called condylomas. 
Approximately two thirds of HPVs infect skin while the 
remaining types infect keratinizing and nonkeratinizing 
squamous epithelia of the anogenital tract or the oral mucosa 
(Jenson et al., 1988) • 
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These mucosotrophic HPVs can be 
classified with respect to oncogenic potential as either low, 
intermediate, or high risk. HPV-6 and -11 are found primarily 
in genital condylomata (Gissman and zur Hausen, 1980, Gissman 
et al., 1983), rarely detected in cervical carcinomas, and 
thus are regarded as low risk viruses. HPV-31, -33, and -35 
are found in appr~ximately 10% of cervical dysplasias, 
primarily premalignant lesions (Lorincz et al., 1987, Fuchs et 
al., 1988), and consequently classified as low or intermediate 
risk types. HPV-16 and -18 are associated with the majority 
of invasive cervical carcinomas, the viral DNA can be detected 
in 85% of cervical carcinoma biopsies (Broker and Botchan, 
1986), and thus are regarded as high risk types (Yoshikawa et 
al., 1985, Mccance et al., 1985). 
Although the highest incidence of carcinomas associated 
with HPV infections is in anogenital tissue, specific HPVs can 
also infect other mucosal surfaces such as the orolaryngeal 
and bronchial mucosa. HPV-6 and 11 are frequently detected in 
benign laryngeal and bronchial papillomas (Gissmann et al., 
1982, Mounts et al., 1982, Ikenberg et al., 1985) while HPV-16 
is also associated with some orolaryngeal tumors, tongue 
carcinonomas (deVilliers et al., 1985), carcinomas of the 
buccal mucosa (Loning et al., 1985) and lung carcinomas 
(Stremlau et al., 1985). However, these cancers are 
relatively infrequent compared to carcinoma of the cervix. 
Growth characteristics of HPVs. Specific phases of the 
8 
HPV infection cycle are restricted to differentiated 
epithelial keratinocytes. The infection cycle begins in the 
proliferating basal layer of epithelial cells. PV infection 
appears to require physical contact of virus to basal cells. 
The cells which are between the squamous and columnar 
epithelium such as those in the nasal mucosa, the larynx, the 
cervix, and at borders of healing wounds are called 
' 
transformation zones• (T-zones) and are especially susceptible 
to HPV infection. These T-zones are a common target for HPV 
infection (reviewed in Broker and Botchan, 1986). The 
mechanism of HPV infection and subsequent early gene 
expression and viral replication is not well understood 
primarily because a cell culture system is not available. 
Although it is possible to grow human keratinocytes in vitro, 
the inability to differentiate these cells does not allow for 
a complete infection cycle. However, Kreider et al., (1985) 
have developed a animal model system to produce an active HPV-
6 infection. Virus-infected cells are engrafted beneath the 
renal capsule of mice resulting in the production of putative 
precancerous lesions. Virus particles can be isolated from 
these lesions. Viral replication occurs in the basal cells 
since in squamous epithelium, keratinocytes only proliferate 
in the basal layer. When cells leave this layer, they undergo 
a sequence of biochemical and phenotypic changes which 
constitutes terminal differentiation. Ultimately, these cells 
are sloughed off as fully differentiated cells (reviewed in 
9 
Eckert, 1989). Viral DNA synthesis has been detected by in 
situ hybridization studies in the stratum spinosum (spiny 
layer) as well as the stratum granulosum (granular layer) of 
the epidermis (Wagner et al., 1984). Thus the lifecycle of 
PVs appears to be closely linked to the state of 
differentiation of squamous epithelial cells (reviewed in Orth 
et al., 1977). 
Latent HPV infections represent the largest reservoir for 
mucosotrophic HPV infections (Jenson and Lancaster, 1990). 
Latently infected tissue does not exhibit any unusual 
morphology compared to normal squamous epithelium (MacNab et 
al., 1986) and viral DNA can be detected only by Southern or 
dot blot analysis of infected tissue. It is not known what 
induces the latent infection to become active although 
mechanical or chemical trauma and infection of regenerating 
squamous cells may lead to recurrence (Ferenczy et al., 1985). 
Molecular characteristics of HPV. The genome of 
papillomaviruses consists of a circular double stranded DNA 
molecule of approximately 8 kilobase pairs (kbp). The viral 
DNA is complexed with histones and has an approximate 
molecular weight of 4.5 x 106 daltons. The viral genome is 
encapsidated in a 55 nm icosahedral shell and the virion lacks 
a lipid containing envelope (Pfister and Fuchs, 1987). The 
genomes of several PVs have been sequenced (Danos et al., 
1982, Schwarz et al., 1983, Seedorf et al., 1985, Cole and 
Danos, 1987) and it is clear that all PVs have a compact and 
10 
rather similar genomic organization. All putative open 
reading frames {ORFs) as well as the long control region {LCR) 
are on one DNA strand. The early (E) genes encode proteins 
which are involved with oncogenic transformation, DNA 
transcription, and replication. The late {L) genes encode the 
structural proteins carrying type-specific and species 
specific antigenic d~terminants (Broker and Botchan, 1986). 
The LCR of HPVs• is the noncoding 10% region of the viral 
genome. It contains transcriptional regulatory elements which 
contribute to the epitheliotrophic nature of HPVs. These 
elements include a tissue specific enhancer {Gius et al., 
1987, Cripe et al., 1987) bound by a cervical cell type 
specific octamer binding protein (Dent et al., 1991), 
glucocorticoid response elements (GREs) {Gloss et al., 1987), 
interferon-responsive elements (Cohen et al., 1988), epidermal 
growth factor response element (EGFRE) (Yasumoto et al., 1991) 
as well as transcription factor binding sites for AP-1 
(Garcia-Carranca et al., 1988), NFI {Gloss et al., 1989) and 
keratinocyte specific transcription factors (Mack and Laimins, 
1991). DNase I footprinting analysis of the HPV LCRs detected 
23 sites specifically bound by nuclear proteins {Gloss et al., 
1989). It appears the epithelial specificity of HPV is due to 
a synergism between cellular factors found at certain 
concentrations in epithelial cells rather than unique factors 
present in these cells (Chong et al., 1991). 
The majority of the HPV genome has been functionally 
11 
mapped. ORF E2 encodes a pleiotropic protein which functions 
as a transcriptional trans-activator (Phelps and Howley, 1987) 
and a transcriptional repressor (Cripe et al., 1987). This 
protein binds as a dimer to conserved palindromic motifs 
repeated several times within the LCR (Gloss et al., 1987). 
The E2 protein binds to SPl sites to transactivate 
transcription (Li et al., 1991) while a truncated E2 represses 
1 
transcription (Cripe et al., 1987). ORF E4 is the most 
abundant gene product in cutaneous HPV-1 infections (Doorbar 
et al., 1986), although no specific function has been 
assigned. The functions of ORFs E5 and El are not yet known. 
ORFs E6 and E7 encode two proteins which can: 1) immortalize 
rodent and human cells (Matlashewski et al., 1987, Kanda et 
al., 1988, Watanabe et al., 1988, Munger et al., 1989), 2) 
transacti vate heterologous gene expression (Phelps et al. , 
1988, Grossman et al., 1989), 3) stimulate cellular DNA 
synthesis ( Sato et al. , 19 8 9) and 4) play a role in the 
maintenence of viral DNA (Berg et al., 1986). E6 and E7 are 
both nuclear proteins (Grossman et al., 1989, Smotkin and 
Wettstein, 1986). E7, the major protein in cervical carcinoma 
tissue, is a 21 kd phosphoprotein (Smotkin and Wettstein, 
1986) . Ll and L2 encode the major and minor structural 
proteins (Doorbar and Gallimore, 1987). 
Pathogenesis of HPV. Integration of HPV DNA into the 
cellular genome was accepted as a prerequisite for progression 
to cervical cancer since many carcinomas contained integrated 
12 
viral DNA while benign HPV lesions contained episomal HPV DNA 
(Durst et al., 1985). However, both episomal and integrated 
forms of complete HPV-16 genomes are present in invasive 
cervical carcinomas (Matsukura et al., 1989) • Thus, 
integration may not be required for malignant progression but 
it is the predominant form of HPV DNA in malignant lesions and 
thought to play an i~portant role. 
Viral integrati-0n usually results in the disruption of 
the El and/or E2 ORFs and retention of E6, E7 ORFs and the LCR 
(Durst et al., 1986, Matsukura et al., 1986, Pater and Pater, 
1985) with subsequent deletion or rearrangement of cellular 
sequences (Wagatsuma et al., 1990, Choo et al., 1990). 
Wagatsuma et al., (1990) analyzed several cervical carcinoma 
clones containing HPV-16 DNA flanked by cellular DNA sequences 
to determine if there is specific integration. No specific 
target sequence was found either in the cellular genome or in 
the HPV-16 viral genome, however, integration frequently 
occurred in the El/E2 ORF (Wagatsuma et al., 1990). 
Therefore, viral integration frequently disrupts the El/E2 ORF 
but not at a specific site within the viral genome. 
Al though propagation of HPV has not been possible in 
vitro, the availability of recombinant viral DNAs has allowed 
for transformation studies of high-risk HPVs specifically, 
HPV-16 and HPV-18. Early genes, E6 and E7, are intact and 
expressed in nearly all malignant lesions (Pater and Pater, 
1985, Matsukura et al., 1986). Both E6 and E7 of high-risk 
13 
HPVs are required to immortalize primary human cells, 
including keratinocytes (Durst et al., 1987, Kaur and 
McDougall, 1988, Woodworth et al., 1989) and fibroblasts 
(Pirisi et al., 1987, Watanbe et al., 1989). E7 alone can 
transform established rodent cells (Kanda et al., 1988, Bedell 
et al., 1989), cooperate with an activated ras to transform 
primary cells (Matlashewski et al., 1987, Phelps et al., 1988) 
and induce chromosomal abnormalities in murine keratinocytes 
(Hashida and Yasumoto, 1991). High-risk HPV infection of 
primary cells does not usually induce tumors in nude mice, 
however, long term cultivation may result in a malignant clone 
(Hurlin et al., 1991). The role of E6/E7 in the initiation 
and maintenence of transformation was demonstrated by von 
Knebel Doeberitz et al., ( 1988) . Transfection of HPV-18 
positive tumor cells (Hela), with hormone-dependent anti-sense 
E6/E7 plasmid constucts resulted in reduced cell growth and 
nontumorigenecity of HPV-containing cervical carcinoma cells. 
A reduction of E6/E7 mRNA and E7 protein levels was detected 
when compared to transfection with the sense orientation of 
E6/E7 constructs (von Doeberitz et al., 1988). Thus, E6/E7 
ORFs play a role in the maintenence of the malignant 
phenotype. 
Many subtle differences exist between the oncogenic and 
nononcogenic HPV types. The physical state of viral DNA 
differs in these two types of infections. In low-risk 
infections, the DNA remains episomal, whereas in high-risk 
14 
infections, the viral DNA is primarily integrated (Durst et 
al., 1985}. The E6/E7 ORFs of the high-risk HPVs can 
immortalize primary human cells while low risk HPVs cannot 
(Sato et al., 1989). The generation of E6/E7 mRNAs also 
differs. The major transcript of mucosotrophic HPVs (both 
high and low risk} is E7. In high-risk HPVs, E7 is generated 
from a colinear E6/~7 transcript by splicing out an intron 
within the E6 ORF. Thus a full length E7 mRNA is synthesized 
along with two short E6 mRNAs (E6*I and E6*II} (Smotkin et al., 
1989}. In contrast, no splice site is present in low-risk 
HPVs and thus only full length E6 and E7 transcripts are 
generated. E6*I and E6*II were thought to encode type-specific 
transforming peptides, however no truncated . proteins were 
isolated. The function of the splice within E6 appears to 
facilitate translation of E7 mRNA and reduce translation of 
full length E6 rather than to generate active E6* proteins 
(Sedman et al., 1991). 
A common effect of infection with high risk HPVs is 
growth stimulation of cells (Hawley-Nelson et al., 1989, Sato 
et al., 1989} leading to chromosomal abnormalities resulting 
in cell aneuploidy (Durst et al., 1987, Smith et al., 1989}. 
cytogenetic abnormalities were correlated with high-risk E7 
gene functions but not with E6 (Hashida and Yasumoto, 1991). 
Aneuploidy is seen primarily with high risk HPV infections, 
while low risk HPVs do not usually cause chromosomal 
aberrations (Fu et al., 1981}. Thus, the ability of E7 to 
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induce chromosomal abnormalities may be important with respect 
to its immortalizing function. 
Role of cellular factors in progression. Specific 
cellular proteins also differ in their ability to bind HPV 
viral oncoproteins. The E7 oncoprotein of high-risk HPVs 
binds to the retinoblastoma (RB) protein with a 10-fold higher 
affinity than E7 pr9teins of low-risk HPVs (Dyson et al., 
1989). E6 binds to the tumor suppressor protein, p53 (Werness 
et al., 1990) and promotes degradation of this cellular 
protein (Scheffner et al., 1990). Both p53 and RB proteins 
are thought to play a role in cellular proliferation by 
negatively regulating cell growth (Sturzbecher et al., 1990, 
Decaprio et al., 1989). Mutations of these genes lead to 
deregulation of the cell cycle resulting in hyperprolif eration 
and chromosoma 1 instabi 1 i ty ( Hudson et a 1 • , 19 9 0 , Woodworth et 
al., 1990) similar to the effect seen with the E6/E7 gene 
products of high-risk HPVs. Therefore, these cellular 
proteins may also be involved in the progression of high-risk 
HPV infections. 
Cell specific factors may also play a role in HPV 
progression. Fusion of HPV positive cervical carcinoma cells 
(Hela) with active E6/E7 expression and normal human cells 
(fibroblasts) produced nonmalignant hybrids suggesting 
cellular factors can override the effect of or downregulate 
E6/E7 expression (Bosch et al., 1990) . The suppressive effect 
of cellular factors was also demonstrated when the HPV-18 LCR 
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was placed upstream of the reporter gene chloramphenicol 
acetyltransferase (CAT). Resulting CAT expression was 
extinguished in hybrids of cervical carcinoma cells (SiHa) 
fused with nontumorigenic immortalized keratinocytes. 
cycloheximide treatment (4 hrs) of hybrids resulted in the 
reappearance of CAT expression suggesting suppression was due 
to a labile prote~n (Rosl et al., 1991) present in 
nonmalignant keratinocytes. Chromosomal aberrations may also 
play a role in HPV pathogenesis. It appears HPV-16 gene 
expression in primary human fibroblasts is stimulated by a 
deletion in one copy of chromosome 11 (Saxon et al., 1986). 
Several studies have demonstrated that integration of 
high-risk HPV DNA into the cellular genome results in 
alterations of the c-myc protooncogene (Riou et al., 1987, 
Durst et al., 1987, Crook et al., 1990). Amplification of the 
c-myc gene (Ocadiz et al., 1987) and enhanced c-myc RNA 
expression (Crook et al., 1990) was observed in several 
cervical carcinomas. HPV-18 integration results in specific 
activation of myc genes in genital tumors (Couturier et al., 
1991). Taken together this suggests the c-myc oncogene may 
also play a role in the pathogenesis of cervical cancer. 
The long latency period, the relatively low number of 
high-risk HPV infected individuals who develop progressive 
cervical cancer as well as the presence of HPV-16 in 
histologically normal tissue (MacNab et al., 1986, Tidy et 
al., 1988) suggests that HPV alone is not sufficient for 
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progression to invasive carcinoma. It has been hypothesized 
that herpes simplex virus 2 (HSV-2) cooperates with the 
oncogenic HPVs to produce the malignant phenotype (zur Hausen, 
1983). 
Growth characteristics of HSV-2. HSV-2 is a large human 
DNA tumor virus of the Herpesviridae family. Classified as an 
alphaherpesvirus, al9ng with herpes simplex virus 1 (HSV-1) 
and varicella-zoster•virus (VZV), it can replicate efficiently 
in a wide host range, spread rapidly in culture due to a short 
life cycle, and cause complete lysis of host cells. In 
addition to a lytic cycle, alphaherpesviruses cause latent 
infections in sensory neurons (Roizman, 1985) • The HSV-2 
virion consists of an enveloped icosahedral capsid enclosing 
a DNA containing viral core. The approximate size of the 
viral genome is 150 kbp. The structure of the HSV genome 
includes two regions of unique sequences, UL and U8 , each 
flanked by a set of inverted repeats (reviewed in Roizman, 
1985) . 
Cytopathic effect (CPE) of replicating virus on host 
cells is seen by an enlargement of cells and dissolution of 
cell nuclei. Viral CPE occurs in the parabasal cells of the 
squamous epithelium. A vesicle filled with cell debris, 
inflammatory and multinucleated giant cells forms under the 
cornified epithelium as cell lysis progesses. The lesion can 
spread into adjacent parabasal cells and rupture, releasing 
viral antigens and evoking a subsequent host cell response 
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(reviewed in Rawls, 1985). 
HSV-2 is primarily spread by sexual contact and risk 
factors associated with these infections are similar to those 
of other sexually transmitted diseases (STD; Stavraky et al., 
1983). In fact, many STD patients have concurrent HSV-2 
infections (Knox et al., 1982). While most HSV-2 genital 
infections are not ltfe threatening, an association between 
HSV-2 and cervical carcinoma seems clear (Rawls et al., 1969, 
Naib et al., 1973, McDougall et al., 1980, Nahmias and 
Norrild, 1980, DiLuca et al., 1989, Hildesheim et al., 1991). 
Role of HSV-2 in transformation. Duff and Rapp (1971, 
1973) demonstrated that HSV-2 can transform mammalian cells. 
Immortalization of hamster embryo fibroblasts was induced by 
ultraviolet (UV) -inactivated HSV-1 virus (Duff and Rapp, 
1973) . Immortalization by inactivated HSV-2, either UV or 
photodynamic, was also demonstrated in rodent (MacNab, 1974) 
and human cells (Takahashi and Yamanishi, 1974). Thus, 
inactivated HSV-2 virus will transform human cells, however, 
virus is not recovered (Takahashi & Yamanishi, 1974, Kucera 
and Gusdon, 1976). Early experiments suggested a "hit and 
run" mechanism to describe HSV transformation since the 
continued presence of HSV was not required for transformation 
(Skinner, 1976, Galloway and McDougall, 1983). 
Within the HSV genome, three unique morphological 
transforming regions (mtr) have been identified. Mtr I is 
contained in the HSV-1 genome and maps to a XbaI-F fragment 
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(map unit 0.30 - 0.45) (Camacho and Spear, 1978). The HSV-2 
genome contains two regions capable of transforming cells, mtr 
II and mtr III. Mtr II is within the Bgl II-N fragment (map 
unit 0.585 - 0.63) while mtr III is contained within the Bgl 
II-C fragment (map unit 0.42 - 0.58) (Galloway and McDougall, 
1981, Jariwalla et al., 1983). The minimal transforming 
region of mtr II is a, 730 bp fragment (Galloway et al., 1983) • 
The HSV-2 mtr III contains a minimal transforming fragment of 
486 bp (486 TF) which apparently does not encode an oncogenic 
protein (Jones et al., 1986). Rather, the viral DNA contains 
multiple regions of alternating purines and pyrimidines, G+C 
rich sequences, potential SPl transcription factor binding 
sites, stem-loop structures and insertion-like elements (Jones 
et al., 1986). 486 TF also functions as a complex 
transcriptional promoter element (Jones, 1989). It was 
hypothesized that the multiple repetitive DNA sequence motifs 
associated with recombination and gene activation in 486 TF 
alter cellular gene expression leading to transformation 
(Jones, 1989). 
Function of RR in HSV-2 mediated transformation. The 
role played by the HSV encoded ribonucleotide reductase (RR) 
proteins in viral transformation has been examined since mRNAs 
encoding this dual subunit protein are within the Bgl II-C and 
Bgl II-N fragments (McLauchlan and Clements, 1982, swain and 
Galloway, 1986). HSV RR is composed of a large subunit, RRl, 
and a small subunit, RR2 (Cohen et al., 1985, Frame et al., 
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1985, Bachetti et al., 1986). The two transcripts have 3'-
coterminal ends with the 1.2 kb mRNA encoding RR2 contained 
within Bgl II-N. The 5. 0 kb mRNA encoding RRl has all but the 
carboxy terminus within Bgl II-C (McLauchlan and Clements, 
1982, swain and Galloway, 1986). HSV-2 RRl was proposed as a 
transformation specific protein (Huszar and Bacchetti, 1983), 
however, 486 TF does,not encode the catalytic function of the 
RRl. This suggests-that RRl expression is not required to 
induce transformation, at least in rodent cells (Jones et al., 
1986). The amino terminus of RRl contains a 355 hydrophilic 
amino acid (aa) domain which does not share homology with 
other herpesvirus RR enzymes (Swain and Galloway, 1986). It 
was recently demonstrated that a 290 aa polypeptide from this 
domain was able to induce enhanced malignant transformation of 
rodent cells (Ali et al., 1991) suggesting the entire RRl 
protein is not necessary for transformation. In summary, the 
exact role RRl or RR2 plays in neoplastic transformation has 
not been established. 
Mutagenic effect of HSV-2. The specific mechanisms of 
transformation of HSV are not known. However, certain aspects 
of HSV resemble chemical mutagens which induce random cellular 
alterations. Since HSV-2 transformation does not appear to 
require retention of viral DNA and a HSV encoded oncoprotein 
has not been identified, it was hypothesized that HSV-2 could 
induce stable, heritable changes in the cell which ultimately 
leads to transformation (Clarke and Clements, 1991). 
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Herpesviruses efficiently induce chromosomal aberrations such 
as breaks and rearrangments (Hampar and Ellison, 1961, Bejcek 
and Conley, 1986) and act as a biological mutagens. Damage is 
followed by cellular DNA repair ( zur Hausen, 1983) . HSV-2 
infections of nonpermissive cells have been shown to increase 
the mutation frequency of the cellular hypoxanthine-guanine 
phosphoribosyl trans¾erase (HGPRT) gene by 2 to 10 fold (Pilon 
et al., 1985). The ~utation rate of HGPRT was 5 to 10 fold 
higher than background when human cells were infected with 
inactivated HSV-1. The effect was comprable to the chemical 
carcinogen 4-nitroquinoline-1-oxide (4-NQO) (Schlehofer and 
zur Hausen, 1982). Neither viral replication nor gene 
expression is required for the mutagenic effect of HSV (Clarke 
and Clements, 1991). Thus, mutagenesis may be an important 
mechanism used by HSV in carcinogenesis. 
Another mechanism by which HSV is suggested to transform 
cells is gene amplification. Studies have demonstrated 
inactivated HSV can amplify genes with similar efficiencies as 
chemical carcinogens (Lavi, 1981, Schlehofer et al., 1983). 
HSV-2 DNA secondary structure has been implicated in the 
transformation process. Both the minimal transforming 
fragments of Bgl II-N (730 bp) (Galloway et al., 1983) and Bgl 
II-C (486 TF) (Jones et al., 1986) have unique DNA sequences. 
Both are able to form stem-loop structures which may promote 
DNA insertions and transpositions (Jones et al., 1986). 
Additionally, 486 TF contains sequences able to form Z-DNA 
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which is implicated in homologous recombination and 
chromosomal destabilization (Nickol et al., 1982). 
Recombination between HSV-2 and cellular DNA can lead to 
deregulation of cellular genes (MacNab et al., 1985, Leavitt 
et al. , 1985) • Viral recombination also results in the 
excision of extrachromosomal plasmids containing viral DNA 
sequences fused to a~tered cellular sequences (Jariwalla et 
al., 1986). Therefore, HSV-2 DNA structure may be an 
important factor in transformation. Recently, the ability of 
HSV-2 to induce cervical neoplasia was demonstrated when 
inactivated whole virus was applied to the mouse cervix and 
analyzed for the presence of premalignant and malignant 
lesions (Anthony et al., 1989). Lesions, similar to those 
seen in women with cervical carcinoma, were detected in 61% of 
the mice of which 21% were invasive carcinomas. No cancers 
were detected in control animals treated with uninfected HEp-2 
cellular DNA or calf thymus DNA (Anthony et al. , 1989) . Thus, 
in an animal model HSV-2 can induce cervical carcinoma. 
Epidemiology of HPV /HSV-2 in cervical carcinoma. studies 
assessing the possible correlation between HSV-2 DNA and high-
risk HPVs in the pathology of cervical carcinomas have looked 
for the simultaneous presence of both viral DNAs in genital 
tumor tissues (DiLuca et al., 1987, 1989, Hildesheim et al., 
1991). Thirty percent of genital tumor tissue had homology to 
HSV-2 mtr II and mtr III fragments (DiLuca et al 1989) while 
6/8 tumors (DiLuca et al., 1989) and 8/8 tumors (DiLuca et 
23 
al., 1987) showing homology to HSV-2 DNA sequences were also 
positive for HPV-16/18 DNA. Seroepidemiological studies have 
shown that women with cervical cancer had higher levels of 
HSV-2 specific antibodies than controls (Kaufman and Adam, 
1986). Hildesheim et al., (1991) found a significant 
interaction between HSV-2 and HPV-16/18. In HPV 16/18 
positive women, HSV-~ seropositive women had a 60% increased 
risk of cervical cancer compared to seronegative women. These 
results suggest a possible synergism between these two 
oncogenic viruses. A transformed keratinocyte cell line with 
HSV-2 mtr II DNA and HPV-16 DNA can produce tumors in nude 
mice. In contrast, HPV-16 immortalized parental cells do not 
(DiPaolo et al., 1990) implying Bgl II-N plays a role in the 
progression to carcinoma. Thus, several lines of evidence, 
molecular as well as epidemiological, implicate HSV-2 and HPV-
16/18 as cofactors in the development of cervical carcinoma. 
The frequent incidence of high-risk HPV nucleic acids in 
cervical carcinoma biopsies has suggested these viruses play 
a role in the induction of genital cancer. However, the 
presence of high-risk HPV containing tissue which is histo-
logically normal (MacNab et al., 1986) suggest other factors 
play a role in progression. HSV-2, with its ability to act as 
a biological mutagen, is a viable candidate to mediate the 
progression of high-risk HPV infection to genital cancer. 
METHODS AND MATERIALS 
Cells. Human fibroblast cells, R-30, N-16, and C-1, were 
obtained from Dr. Tom Hassell. These cells were split in 1:3 
ratios weekly and ma~ntained in Earles modified Eagles medium 
(Sigma) supplemented with 10% fetal bovine serum (Sigma), 
penicillin (10 U/ml), and streptomycin (100 ug/ml). Primary 
human keratinocytes, FE-A, and FEP-L (HPV-18, HPV-16 
immortalized cell lines) were obtained from Dr. James 
McDougall. Keratinocytes were maintained in serum-free 
keratinocyte medium (Gibco) supplemented with epidermal growth 
factor (5 ng/ml) and bovine pituitary extract (50 ug/ml), 
penicillin (10 U/ml) and streptomycin (100 ug/ml). Cells were 
split 1:4 weekly. 
Plasmids. Plasmid HZIP-16 was obtained from Dr. G. 
Matlashewski and contains 6.6 kb of the HPV-16 genome flanked 
by the Moloney murine leukemia virus long terminal repeats 
(Matlashewski et al., 1987). A 1.3 kb fragment of the Ll ORF 
was deleted for cloning purposes. All other ORFs are 
undisturbed. Plasmid pEJ6.6 containing the Ha-ras oncogene 
was obtained from ATCC (#41028, Rockville, MD). Plasmid 
pHPV18 containing the entire HPV-18 genome (7857 bp) was 
obtained from Dr. James McDougall. Two c-myc plasmids were 
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used in the analysis. Plasmid p5-UTR containing a 1.6 kb Sac 
I fragment of the 5'-untranslated region of the c-myc gene, 
was obtained from ATCC (#39286, Rockville, MD) and plasmid 
pEX2, containing a 420 bp Pst I fragment of exon 2 of c-myc 
DNA, was obtained from Dr. Len Erickson. Plasmid php53 
containing a 2.1 kb Bam HI human p53 cDNA insert was obtained 
from Dr. Moshe Oren., All of the HSV-2 plasmids contained 
various sequences derived from HSV-2 mtr III and contained the 
ampicillin resistance gene (Jones et al., 1986). 
Calcium phosphate transfection of fibroblasts. Low 
passage R-30 cells or N-16 cells were transfected with 25 ug 
DNA using calcium phosphate precipitation (Graham and Van der 
Eb, 1973). A 25% DMSO shock was used to facilitate uptake of 
DNA following calcium phosphate precipitation. Seventy two 
hours after transfection, the antibiotic geneticin (Sigma) was 
added to the cultures (400 ug/ml) to select for cells 
containing plasmids. All cultures were cotransfected with 
pSV2neo (5 ug/60mm dish). Geneticin selection was carried out 
for 2-3 weeks post transfection or until all the cells in the 
control dish were dead. When densely growing colonies became 
macroscopic in size, the cells were trypsinized and 
subcultured as described above in the absence of geneticin. 
Polybrene transf ection of keratinocytes. Due to the 
toxicity of calcium phosphate on keratinocytes, the polybrene 
transfection method (Rhim et al., 1986) was used for these 
cells. Polybrene, hexadimethrine bromide (Sigma), is a 
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cationic compound which disrupts cell membranes and allows for 
DNA passage into cells. Either normal human keratinocytes 
(NHK) or immortalized HPV cell lines, FE-A containing HPV-18 
or FEP-L containing HPV-16, were transfected with 10 ug 
plasmid DNA using 10 ug polybrene (1 mg/ml) in 1 ml serum-free 
medium ( SFM) • Cultures were incubated at 37° c and rocked 
every hour. A 30% DMSO shock (4 minutes) was performed after 
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6 hours to facilita.te uptake of DNA. All cultures were 
cotransfected with pSV2neo (2 ug/60 mm dish). Forty eight to 
seventy two hours after transfection, geneticin was added to 
cultures (50 ug/ml for FE-A cells and 500 ug/ml for FEP-L 
cells) to select for cells with plasmids. Genetic in selection 
was carried out for 3-5 weeks post transfection or until the 
control cells were dead. When densely growing geneticin 
resistant cells became macroscopic, cells were trypsinized and 
cultured in the absence of geneticin. 
Isolation of high molecular weight DNA. This procedure 
has been previously described by Maniatis et al., (1986). 
Tissue culture cells were washed and trypsinized. Cells were 
centrifuged for 10 minutes. The pellet was washed in TKMC 
solution ( 10 mM Tris pH 7. 5, 10 mM KCl, 1 mM MgC12 , 5 mM CaC12 ) 
and resuspended in 500 ul TKMC solution and 25 ul 10% Triton 
X-100 and incubated on ice for 5 minutes. The cell suspension 
was centrifuged and the pellet resuspended in 250 ul TNE 
solution (50 mM Tris pH 7.5, 100 mM NaCl, 10 mM EDTA), 2.5 ul 
10% SOS and 100 ug RNase A. Samples were incubated at 37° C 
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for 1.5 hours and 7.5 ul Proteinase K (20 mg/ml) was added and 
samples were incubated overnight at 37° c. The samples are 
extracted two times with phenol: chloroform: isoamyl alcohol 
(50:49:1). Two volumes of 95% ethanol was added and samples 
were shaken for an additional 30 minutes followed by a 5 
minute spin. The ethanol precipitation was repeated. The 
pellet (after a secon~ ethanol wash) was dried and resuspended 
in TE buffer ( 10 mM Tris-Hcl, pH 7. 4, 1 mM EDTA) • The genomic 
ONAs were digested with the indicated restriction enzyme (10 
U/ug). The quantities of DNA was estimated by 
electrophoresing on a 1% minigel. 
Plasmid DNA isolation. Large scale isolation and 
minipreparations of plasmid DNA were performed by the alkaline 
lysis method described by Maniatis et al., (1989). For large 
scale isolation, the bacteria with the respective plasmid were 
shaken in overnight 5 mls of Luria broth (LB) with 50 ug/ml 
ampicillin (Sigma). This 5 ml preculture was used to 
inoculate a one liter LB culture containing 50 ug/ml 
ampicillin. The culture was incubated at 37° C with vigorous 
shaking until it reached an O.D. 595 of 0.6-0.7. Fifty ug/ml 
chloramphenicol (Sigma) was subsequently added to cultures and 
incubation with shaking was continued overnight. Bacteria 
were harvested by centrifugation at 8000 rpm for 10 minutes at 
4° c in a Beckman JA-10 rotor. The pellet was resuspended in 
9 ml of solution I containing 50 mM glucose, 25 mM Tris-HCl, 
pH 8. o, 10 mM EDTA, pH 8. o. Bacterial membranes were 
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disrupted by addition of 1 ml fresh lysozyme solution (5 mg 
1ysozyme in solution I) and incubated for 5 minutes at room 
temperature. Cells were lysed by addition of 20 ml of 
solution II containing 0.2 N NaOH, 1% sos (w/v) and kept on 
ice for 10 minutes. Twenty ml of an ice-cold solution of 5 M 
potassium acetate (pH 4.8) was added and tubes were shaken 
vigorously and subsequently incubated on ice for 10 minutes. 
, 
The lysates were tran~ferred to two 50 ml Oak Ridge tubes and 
centrifuged at 20,000 rpm at 4° C in a Beckman JA-20 rotor for 
20 minutes. The supernatant was transferred to 2 new Oak 
Ridge tubes and 0.6 volume of isopropanol added. DNA was 
precipitated for 15 minutes at room temperature and tubes were 
centrifuged for 30 minutes at 20° C in the Beckman JA-20 
rotor. The pellets were resuspended in 2.4 ml TE buffer. 
For purification of supercoiled plasmid DNA, cesium 
chloride (CsCl)-ethidium bromide equilibrium centrifugation 
was performed. For each ml of DNA solution, 1 g CsCl and o.a 
ml ethidium bromide (10 mg/ml) was added. The samples were 
centrifuged in a Beckman VTi 70 rotor at 50,000 rpm for 20 
hours at 20° c. Closed circular plasmid DNA was removed by 
side puncture and the CsCl gradient was repeated. Ethidium 
bromide was removed by repeated extraction with isoamyl 
alcohol saturated with CsCl. Plasmid DNA was precipitated by 
adding 8 ml TE buffer (to reduce CsCl concentration), two 
volumes of ethanol and incubated at -20° c overnight. DNA was 
pelleted by centrifugation at 12,000 rpm for 30 minutes at 4° 
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c and resuspended in TE buffer. 
For minipreparations of plasmid DNA, a 1.5 ml LB culture 
with 50 ug/ml ampicillin and the specific bacterial colony was 
incubated at 37° c with vigorous shaking overnight. Samples 
were centrifuged for 1 minute and resuspended in 100 ul 
solution containing 50 mM glucose, 10 mM EDTA pH 8.0, 25 mM 
Tris-Hcl pH 8.0, 4 mg/ml lysozyme and incubated for 5 minutes 
at room temperature.· To the cell suspensions, 200 ul of a 
fresh solution of 0.2 N NaOH, 1% SOS was added followed by 
another 5 minute incubation at room temperature. One hundred 
fifty ul of an ice-cold solution of 5 M potassium acetate (pH 
4.8) was added, samples placed on ice for 5 minutes, and 
subsequently centrifuged for 5 minutes at 4° c. The 
supernatant was extracted with an equal volume of 
phenol:chloroform:isoamyl alcohol (25:24:1). The aqueous 
layer was removed. DNA was precipated by the addition of 2 
volumes of ethanol for 10 minutes at room temperature and 
pelleted by centrifugation. Pellets were washed with 70% 
ethanol, dried in a vacuum, and resuspended in TE buffer. 
Electrophoresis. Two types of gel electrophoresis were 
performed. 
a) Agarose gel electrophoresis. Undigested and 
digested genomic DNA samples were analyzed by electrophoresis 
on horizontal 1% agarose gels. Gels were prepared in a buffer 
(lX TBE) containing 89 mM Tris-borate, 2 mM disodium EDTA, pH 
8.0 (TBE) and 0.5 ug/ml ethidium bromide (w/v). Samples were 
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suspended in TE buffer and gel loading dye (250 mM EDTA, 1% 
sos, 0.1% bromphenol blue (w/v), 50% glycerol). 
Electrophoresis was carried out at 5 V/cm for 3 hours and lX 
TBE used as the running buffer. 
b) Polyacrylamide gel electrophoresis {PAGE). Small 
DNA fragments digested with restriction endonucleases were 
separated on 6%, nondenaturing polyacryamide gels. 
Electrophoresis was carried out for 16 hours at 5 mA in lX TBE 
buffer. Gels were stained with 5 ug/ml ethidium bromide and 
subsequently visualized with an ultraviolet transilluminator 
(305 nm). 
Isolation of DNA fragments from agarose or PAGE gels. 
Agarose or polyacrylamide gels stained with e~hidium bromide 
were visualized with an ultraviolet transilluminator. 
Specific DNA bands were excised from the gel with a razor 
blade and placed into dialysis bags containing 500 ul TE 
buffer. The DNA was electroeluted from the gel slice in 0.5X 
TBE running buffer (Maniatis et al., 1986). The DNA was 
purified by phenol:chloroform:isoamyl alcohol {25:24:1) 
extraction, an ether extraction, and concentrated by ethanol 
precipitation. 
Labelling of DNA probes. Probes labelled with 32P-dCMP 
were prepared by random priming from a kit by IBI using 
[alpha-32PJ-dCTP. The labelled probes were separated from 
unincorporated nucleotides by Sephadex G-50 (Pharmacia) 
chromatography. The probes were eluted with NETS solution 
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containing 0.1% SOS, 100 mM NaCl, 10 mM Tris-HCl, pH 8.0, 1 mM 
disodium EDTA, pH 8. o. Separation of probe from 
unincorporated nucleotides was monitored with a Geiger 
counter. Specific activity of the probe was approximately 5-
10 X 107 cpm/ug DNA. 
southern blot hybridization. Prior to blotting agarose 
gels, DNA was parti~lly depurinated in O. 25 N HCl for 15 
minutes, denatured ift 0.5 M NaOH-0.9 M NaCl for 1 hour (two 30 
minute incubations) and neutralized in 0.5 M Tris-HCl- 0.9 M 
NaCl (pH 7.6) for 1 hour (two 30 minute incubations). The 
gels were subsequently transferred to nitrocellulose (Micron 
Separations, Inc., Westboro, MA) (Maniatis, 1989) with 20X SSC 
( lX SSC is 150 mM NaCl, 15 mM Na-citrate, pH 7. 0) . The 
membranes were prehybridized in 50% formamide, 5X SSC, 0.1% 
sos (w/v), 0.05M disodium phosphate, pH 6.8, 2X Denhardt's (lX 
Denhardt's is 0.02% ficoll, 0.02% polyvinylpyrrolidone and 
0.02% bovine serum albumin) and 50 ug/ml sheared salmon sperm 
DNA for 2 hours at 42° c. The hybridization solution 
contained the same components as the prehybridization solution 
in addition to the heat-denatured probe. Membranes were 
hybridized at 42° c overnight. The filters were washed 3 
times in 2X SSC, 0.2% SOS for 20 minutes each and subsequently 
washed 3 times in o. 2X SSC, O. 5% SOS for 2 O minutes each. All 
filters were air dried and placed in X-ray cassettes with 
Cronex Lightning Plus intensifying screens (DuPont) and Kodak 
X-OMAT AR film at -80° C. 
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Isolation of total cellular RNA. Total cellular RNA was 
extracted from cells by the method of Chomczynski and Sacchi 
(1987). Cells (approximately 1 x 106) were washed with 
phosphate-buffered saline (PBS) and lysed with 1.8 ml of a 
solution containing 4 M guanidine thiocyante, 25 mM sodium 
citrate, pH 7.0, 0.5% sodium lauryl sarcosinate, and 0.1 M 2-
mercaptoethanol. Ly~ates were transferred to new tubes to 
which 180 ul of 2 M sodium acetate, pH 4.0, 1.8 ml of water-
saturated phenol and 360 ul chloroform:isoamyl alcohol (49:1) 
was added to each sample. Samples were incubated on ice for 
15 minutes followed by a 30 minute centrifugation at 4000 rpm 
at 4° c. The aqueous phase was transferred to new tubes and 
RNA was precipitated overnight at -20° c with an equal volume 
of isopropanol. RNA was pelleted by a 30 minute spin at 4000 
rpm at 4° C. The RNA pellet was resuspended in 200 ul lysis 
solution and reprecipitated in a microfuge tube. The pellet 
was resuspended in TE and stored at -70°C. 
Cloning HPV-16 DNA fragments into recombinant plasmids. 
Plasmid HZIP-16 was digested to completion with Bam HI, to 
remove the HPV-16 DNA insert, followed by digestion with Pst 
I to obtain vector-free HPV-16 fragments. Plasmid pT7T3 
containing dual opposable RNA polymerase promoters, T7 and T3, 
was also digested with Bam HI and Pst I or with Pst I alone. 
To prevent self-ligation of the vector, the 5' -phosphate 
groups were removed with bacterial alkaline phosphatase (IBI). 
All DNAs were ethanol precipitated and resuspended in TE 
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buffer. The ligation reaction mixture contained vector and 
insert DNA at a concentration ratio of 1:1 and 1 unit of T4 
ligase. Reactions were incubated overnight at 15° c. 
A 5 ml culture of Escherichia coli strain HBl0l was grown 
overnight and used to inoculate 100 ml of LB. The culture was 
grown until O.D. 595 of 0.6-0.7. Cells were pelleted at 2000 
rpm for 10 minutes (JpuAn CR412), resuspended in 20 ml of 100 
mM CaC121 centrifuged again for 10 minutes at 2000 rpm, 
resuspended in 10 ml 100 mM CaC12 and incubated on ice for 1 
hour. Bacteria was added in either a 200:1 or 20:1 ratio 
(v/v) to the ligation mixture. Samples were incubated on ice 
for 40 minutes followed by a 2 minute incubation at 45° c. 
Subsequently, 1 ml of LB and 3 ml of top agar ,(0.137 M NaCl, 
10% casein hydrolysate, o. 8% agar) was added and 
transformation mixtures were poured onto LB agar plates 
containing 50 ug/ml ampicillin. Colonies resistant to 
ampicillin were analyzed for insert DNA by restriction 
endonuclease analysis after mini-preps were performed as 
described above. 
Generation of RNA probes. RNA probes were generated by 
in vitro transcription kits from Ambion. Target DNA was 
cloned into multipurpose cloning vectors with dual opposable 
RNA polymerase promoters, pSP6T7, pT7T3. To detect mRNA, 
complementary RNA or antisense RNA was synthesized. Vector 
DNA was linearized with a restriction endonuclease on the 
amino terminus of the encoded gene product to generate 
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antisense transcripts. Template DNA was extracted with 
phenol:chloroform:isoamyl alcohol (25:24:1) followed by an 
ether extraction to remove any RNAses, precipitated and 
resuspended in TE buffer. For the in vitro transcription, the 
reaction contained 1 ug of linearized template DNA, 1 ul of 10 
mM stock concentrations of ATP, GTP, and CTP, 2 ul of l0X 
transcription buffer, (supplied by Ambion), 1 ul of 200 mM 
dithriotol (DTT), 1 ul placental ribonuclease inhibitor, 5 ul 
of [ alpha-32P]-UTP ( 400-S00Ci/mmol) , and 1 ul of the specific 
RNA polymerase needed for generation of the antisense 
transcripts. The reaction was incubated at room temperature 
for 30 minutes and the reaction terminated by the addition of 
1 ul of DNase I for 15 minutes at 37° c. Subsequently, 20 ul 
gel loading buffer (80% formamide, 0.1% xylene cyanol (w/v), 
0.1% bromphenol blue (w/v), 2 mM disodium EDTA) was added and 
samples denatured for 5 minutes at 85° c, and electrophored on 
8 M urea/5% acrylamide gels at 150 V for 30 minutes. The gel 
was autoradiographed, the full length RNA transcript excised, 
the gel slice placed in 350 ul elution buffer (0.5 M ammonium 
acetate, lmM disodium EDTA, 0.1% SOS), and eluted overnight at 
37° c. The amount of radioactivity present in the eluted 
probe was determined by liquid scintillation counting. 
Northern blot hybridization. Total cellular RNA (10 ug) 
was electrophoresed through a 1% agarose gel containing 0.66 
M formaldehyde and lX MOPS buffer (200 mM 3-[N-
morpholinopropane-sulfonic acid], 5 mM sodium acetate, pH 7. 0, 
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1 mM disodium EDTA). Prior to electrophoresis, 10 ug RNA was 
precipitated and redissolved in sample buffer containing 0.75 
ml deionized formamide, o .15ml l0X MOPS, 0. 24 ml formaldehyde, 
o .1 ml RNase free water, 0 .1 ml glycerol and o. 08 ml 10% 
bromphenol blue {w/v). RNA was transferred to nylon filters 
(Hybond N+, Amersham) by blotting overnight in 20X SSPE {lX 
SSPE contains 0.18 ~ NaCl, 0.01 M sodium phosphate, 1 mM 
disodium EDTA, pH 7. 7). Probes labelled with (alpha-32P]-dCTP 
{l x 107 cpm/ug DNA) were prepared by random priming and 
hybridized to filters in a solution containing 5X SSPE, 5X 
Oenhardt's solution, 0.5% SOS, 50% formamide and 50 ug/ml 
sheared salmon sperm DNA. Hybridization was carried out at 
42° C for 16 hours. The filters were washed with 2X SSPE and 
0.1% SOS two times for 10 minutes at room temperature followed 
by lX SSPE and 0.1% sos for 15 minutes at 65° c. Filters were 
air dried and autoradiographed. 
Ribonuclease protection analysis. Ribonuclease 
protection analysis {RPA) was performed using the RPA kit by 
Ambion. An in vitro generated RNA probe {7 x 104 cpm 32P-UTP) 
was mixed with 10 ug total cellular RNA. Samples were 
precipitated with 0.5 M ammonium acetate and 2.5 volumes of 
ethanol and resuspended in a hybridization buffer {80% 
formamide, 40 mM PIPES pH 6.4, 400 mM sodium acetate, pH 6.4, 
1 mM EOTA), denatured for 4 minutes at 85°C and hybridized 
overnight at 45° c. Unprotected single stranded RNA on 
hybrids was digested with a solution containing RNase A/RNase 
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Tl for 30 minutes at 37° C. Equal volumes of 20% SOS and 
proteinase K were added and samples incubated for 15 minutes 
at 37° c. Subsequently, samples were extracted with 
phenol:chloroform:isoamyl alcohol (25:24:1). The RNAs were 
precipitated with 2. 5 volumes of ethanol and run on a 8 M 
urea/5% acrylamide denaturing gel to separate the RNA species. 
The gel was dried and subjected to autoradiography. 
Anchorage indep~ndent growth analysis. To determine to 
cloning efficiency of transformed cells in soft agar, 
anchorage independent analysis was done. Base plates were 
made with equal volumes of 1. 2% molten agar and 2X growth 
medium containing Eagle's modified Essential medium, 
glutamine, sodium bicarbonate (pH 7. 2), 20%. fetal bovine 
serum, penicillin (10 U/ml) and streptomycin (100 ug/ml) 
resulting in a 0.6% agar mixture. Cells suspensions (1 X 105 
cells) diluted in lX growth medium were mixed with equal 
volumes of 0.6% agar and immediately poured onto base plates. 
Plates were allowed to solidify at room temperature and 
transferred to a 37° c C02incubator. Colonies were counted 
after 2-4 weeks. 
Polymerase chain reaction (PCR} analysis. High molecular 
weight DNA was prepared from various cell lines as previously 
described and digested with either Eco RI or Pst I overnight 
at 37° c. Oligonucleotide primers (Genosys Biotechnologies) 
21 bases in length, were chosen to amplify a target sequence 
of 366 base pairs located within the HSV-2 mtr III 486 TF 
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sequence. The primers were synthesized according to the 
published sequence of 486 TF (Jones et al., 1986}. Primer 917 
contained nucleotides 917 to 937 of the plus strand (5'-
TCACGGAGGACGACTTTGGGC-3') and primer 1262 contained 
nucleotides 1262 to 1282 of the minus strand (5'-
GCGTGTTCGGGGTGCTGTGGA-3'). The probe used to detect the 
amplified sequence w~s the 486 TF sequence (486 bp). PCR was 
performed in 100 ul• volumes in standard commercial buffer 
(Promega) containing 1.5 mM MgC12 • Cycling parameters for PCR 
were: 1 minute at 94° C for denaturation, 1 minute of primer 
annealing at 60° c, and 2 minutes at 72° c for extension. A 
total of 40 cycles was run. For PCR, 1 ug of template DNA was 
used. Amplification products were analyzed on 2% Nu-Sieve 3: 1 
agarose (FMC Bioproducts) gels containing lX TBE buffer and 
0. 5 ug/ml ethidium bromide. Subsequently, Southern blot 
analysis of the gels was done using random primed 32P-labelled 
486 TF probes. Prehybridization was carried out for one hour 
at 61° C in 5X SSPE, 5X Denhardt's and 1% sos. Blots were 
hybridized in the same solution to which the denatured probe 
was added. Membranes were washed in lX SSPE and 1% sos three 
times at room temperature and once at 65° c. Filters were air 
dried and subjected to autoradiography. 
Precautions were taken to avoid DNA carryover. Isolation 
of pre-target and post-target DNA was done in physically 
different areas, disposable labware and positive displacement 
pipettes were used for all DNA manipulations, and protective 
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covering for clothing, hair and face was used. A positive 
control for all PCR analysis was a plasmid, p486, containing 
the 486 TF insert (Jones et al., 1989). Negative controls 
were DNA from normal cells (either keratinocytes or 
fibroblasts) containing no virus (neither HPV-16, -18 or HSV-
2) and the "no template" reactions which contain all 
components of the PCR, reaction except template. "No template" 
lanes provided a control on the performance of the PCR. 
Tumorigenicity assay in nude mice. To determine the 
oncogenic potential of transformed cell lines, 5 x 106 cells 
were injected subcutaneously into nu/nu mice (Harlan Sprague 
Dawley). Mice were observed weekly for the presence of 
lesions. Seven to eight weeks post-injection_, animals were 
sacrificed and lesions removed. Tumorigenic cells were 
dislodged from tissue with Dispase (Boeringer Mannheim) 
overnight and subsequently plated in serum-free keratinocyte 
medium (Gibco). 
RESULTS 
To demonstrate that human papillomavirus types 16/18 and 
human herpes virus-2 can act as cofactors in the development 
of cervical cancer, the experimental approach taken was to 
' 
establish human cells containing both viral DNAs. The first 
half of the Results section will examine and characterize 
primary fibroblast cell lines generated from two human cell 
strains. The second half of the Result section will examine 
cell lines generated from primary genital keratinocytes 
transfected with transforming domains of both viruses. 
Selection of primary human fibroblasts. Two primary 
human cell types derived from gingival tissue were utilized. 
Gingival fibroblasts were obtained from 1) a normal individual 
(N-16) and 2) from an epileptic patient treated with phenytoin 
(R-30), an anti-seizure drug (Delgado-Escueta et al., 1983). 
A common side effect of phenytoin is the induction of gingival 
overgrowth. Approximately 50% of patients taking this drug 
have gingival hyperplasia and overgrowth can lead to complete 
obstruction of teeth {Hassell et al., 1983). Pseudolymphoma 
syndrome and Hodgkin's disease are associated with prolonged 
use of phenytoin (reviewed in Wolf et al., 1985). Cells were 
scraped from gingival tissue of normal and epileptic patients 
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and primary cultures developed from the respective tissue. 
This aspect of the investigation was designed to determine if 
R-30 cells (hyperplastic in vivo) and N-16 cells (normal 
primary cells} differ with respect to morphological 
transformation by HSV-2 and/or HPV-16. 
Transfection analysis of fibroblast cell lines. To test 
for morphological tr~nsformation of R-30 and N-16 cells, a 
plasmid containing ·the early genes of HPV-16, HZIP-16 
(Matlashewski et al., 1987) (Figure 1), was transfected either 
alone or in combination with plasmids containing HSV-2 
sequences derived from morphological transforming region III, 
mtr III (Jones et al., 1986}, into the respective cell lines. 
In addition, a plasmid containing an activat~d H-ras gene, 
pEJ6.6, was cotransfected with HZIP-16 to serve as a positive 
control for cooperation with HPV-16. Matlashewski et al., 
(1987} demonstrated HPV-16 and H-ras could cooperate to 
transform primary cells. Table 1 shows the results from the 
transfection experiments using N-16 and R-30 parental cells. 
Phenytoin-treated cells (R-30) were more susceptible to 
immortalization by HZIP-16 alone compared to fibroblasts from 
a normal individual (N-16). These differences were not merely 
due to higher levels of plasmid DNA uptake in R-30 cells since 
both cell types contained similar levels of DNA at 48 hours 
post transfection (data not shown). When H-ras, an activated 
cellular oncogene, was transfected into R-30 cells or N-16 
cells alone, densely growing genetic in resistant colonies were 
Figure 1. Schematic map of HPV-16 and HZIP-16. 
(I) Restriction enzyme map of HPV-16 genome and location of 
oRFs. The prototype HPV-16 genome is depicted. To construct 
HZIP-16, the region between Barn HI and Eco RI was deleted by 
Matlashewski et al (1987). HZIP-16 contains Molo"ney murine 
leukemia virus LTRs, a neomycin resistance gene, origins of 
replication of SV40 and pBR322 vector sequences. LCR is the 
long control region of HPV-16. Restriction enzyme sites are 
K (Kpn I), H (Hine II), S (Stu I), E (Eco RI) and B (Barn HI). 
This plasmid was used as source of HPV-16 DNA to, generate all 
fibroblast cell lines. 
(II) Restriction map of HSV-2 mtr III region containing 486 
TF. 
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Table 1. Transfection analysis of R-30 and N-16 cells. 
R-30 N-16 
Exp 1 Exp 2 Exp 3 Exp 1 Exp 2 Exp 3 
HZIP-16/H-ras 4 7 5 3 6 7 
HZIP-16/486 TF 5 4 6 4 3 5 
HZIP-16/BglII-C 6 2 7 0 3 0 
HZIP-16 5 7 4 0 1 0 
H-ras 1 0 0 0 0 0 
HSV-2 486 TF 0 0 0 0 0 0 
HSV-2 BglII-C 0 0 0 0 0 0 
pSV2neo 0 0 0 0 0 0 
R-30 or N-16 cells (5 x 105 cells/60 nun dish) were transfected with 25 ug of 
plasmid DNA using the calcium phosphate precipitation procedure (Graham and 
Van der Eb, 1973) followed by geneticin selection (400 ug/ml). Values 
indicate the number of geneticin resistant colonies per 60 nun dish. 
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not observed. The geneticin resistant colony observed in H-ras 
transfected R-30 cells senesced when trypsinized and 
transferred to a new dish. Furthermore, cells transfected 
with pSV2neo alone did not yield densely growing geneticin 
resistant colonies. Since an activated H-ras oncogene will 
transform immortalized human and rodent cells but usually not 
primary cells (Newbold and Overell, 1983, Sager et al., 1983), 
it appears R-30 and· N-16 cells are not immortalized. When 
geneticin resistant colonies from N-16 cells were trypsinized 
and passaged (three independent experiments and resistant 
colonies from 12 plates transfected with HZIP-16 alone, HZIP-
16/H-ras or HZIP-16/486 TF, HZIP-16/Bgl II-C, HZIP-16/Bam HI-
E), stable cell lines were not obtained regardless of the 
transforming sequences transfected into these cells. 
Typically these cells senesced after only four or five 
passages. In contrast, geneticin resistant colonies obtained 
from R-30 cells transfected with HZIP-16 alone or in 
combination with H-ras or HSV-2 DNA sequences underwent at 
least 75-80 population doublings (PD) after trypsinization of 
the original colony in the absence of geneticin. Table 2 
contains a summary of the fibroblast cell lines and the 
primary cells used in the analysis. In summary, these studies 
demonstrated that HPV-16 DNA immortalized R-30 cells more 
efficiently than N-16 cells and neither cell strain was 
transformed by H-ras alone. 
Retention of viral DNA in transformed cell lines. The 
Table 2. Fibroblast cell lines. 
PRIMARY or PRIMARY-LIKE CELLS: 
CELL 
N-16 - primary gingival fibroblasts 
R-30 - hyperplastic gingival fibroblasts 
(phenytoin treated) 
C-1 - cyclosporin treated gingival 
fibroblasts 
LINES: 
139 - HZIP-16 I H-ras 
140 - HZIP-16 I HSV-2 486 TF 
141 
-
HZIP-16 I HSV-2 Bgl II-C· 
145 - HZIP-16 
181 - HZIP-16 
227 
- HZIP-16 I {H-ras + 486 TF} 
228 - HZIP-16 I H-ras 
268 
- HZIP-16 I HSV-2 Bam HI-E 
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Early passage primary and primary-like fibroblast cells 
used in the analysis. The transformed cell lines 
generated from calcium phosphate transfection and 
subsequent geneticin selection. 
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various cell lines were analyzed to detect retention of 
transfected DNA. HPV-16 DNA is generally integrated in 
malignant lesions in vivo (Durst et al., 1985) and thus it 
was of interest to assess the presence of HPV-16 DNA sequences 
in transformed cell lines. When an EcoRI digest of genomic 
DNA was probed with HPV-16 DNA, it was evident all transformed 
cell lines retained HPV-16 DNA (Figure 2). In all cell lines 
except cell line 139,·a 9.4 kb HPV- specific hybridizing band 
was detected. Minor bands which also hybridized to the HPV 
probe were detected in cell line 140 (7.5 kb band) and cell 
line 145 (7.9 kb). In cell line 139, two HPV-specific bands 
(12.5 kb and 6.4 kb) were detected. Since a recent report 
demonstrated that HPV-16 can be detected in oral epithelial 
tissue (Yeudall and Campo, 1991), it was important to 
determine if HPV-16 sequences were present in R-30 cells. As 
expected, the HPV probe did not hybridize to R-30 genomic DNA. 
The intensity of HPV-16 specific hybridization to DNA prepared 
from the various cell lines differed dramatically. Since the 
amount of DNA loaded into each lane was similar, these results 
indicated cell line 145 (R-30 transfected with HZIP-16 alone) 
and cell line 140 (R-30 cells cotransfected with HZIP-16 and 
HSV-2 486 TF) had approximately equivalent amounts of HPV-16 
specific DNA. Cell line 141 (R-30 cotransfected with HZIP-16 
and BglII-C) and cell line 139 (R-30 cotransfected with HZIP-
16 and H-ras) also had equivalent amounts of HPV-16 specific 
DNA, however, at lower levels compared to cell lines 140 and 
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Figure 2. EcoRI digest of DNA from cell lines. Genomic DNA 
was prepared from the various cell cultures (Maniatis et al, 
1982), digested with EcoRI and subjected to Southern blotting. 
(A) R-30, (B) 139, (~) 140, (D) 141, (E) 145. The probe was 
derived from the Pst I-A and Pst I-B fragments of HPV-16. 
Asterisks denote the site of migration of Eco RI digestion 
products of HZIP-16. Molecular size markers, lambda DNA/Hind 
III, are shown in kb (23, 9.0, 6.6, 4.4, 2.3, 2.0). 
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145. When uncut genomic DNA of the respective cell lines was 
probed with HZIP-16 sequences, the hybridizing fragment 
migrated with the high molecular weight genomic DNA suggesting 
integration had occurred (Figure 3). Lane H contains uncut 
HZIP-16 plasmid. Both relaxed and supercoiled forms of the 
plasmid hybridize to the HPV-16 probe as well as DNA from 
transformed and immortalized cell lines while no hybridization 
is detected with R-30 and N-16 genomic DNA. These studies 
indicated HPV-16 DNA sequences were retained in all cell lines 
and the level of HPV-16 specific DNA varied among the 
respective cell lines. 
To map which regions of the HPV-16 genome were retained 
in the various cell lines, Southern blots were probed with 
individual PstI fragments of the HPV-16 genome. Since all of 
the Pst I fragments hybridized to DNA prepared from cells with 
HZIP-16 but not control cells, it appears the entire genome of 
HPV-16 was retained (Figure 4). Furthermore, the regions were 
retained at different copy levels in the various cell lines. 
In addition to seeing intact Pst I fragments (fragments 
migrating with control HZIP-16/Pst I/Barn HI), a number of 
different sized bands also hybridized to the probes. This 
agrees with our conclusion that HPV-16 DNA has integrated into 
the cellular genome and may also suggest tandem duplications 
of the HPV-16 genome occurred. These studies indicated the 
genome of HPV-16 was retained in all cell lines and the copy 
level of HPV-16 DNA varied dramatically among the respective 
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Figure 3. Analysis of undigested high molecular weight DNA 
from fibroblast cell lines. Genomic DNA prepared from 
fibroblast cell lines was subjected to Southern blotting. 
Undigested DNA was used to determine integration of HPV-16 DNA 
sequences into the high molecular weight DNA species. The 
probe used was the 6.6 kb HPV-16 Barn HI insert from HZIP-16. 
Lane (A) N-16, (B) R-30, (C) 139, (D) 140, (E) 141, (F) 145, 
(G) 181, (H) HZIP-16. 
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figure 4. Analysis of HPV-16 DNA in transformed R-30 cells. 
(I) High molecular weight DNA was prepared from the various 
transformed cells, digested with the restriction enzyme PstI, 
and subjected to Southern blot analysis. Southern blots were 
probed with the individual PstI or PstI/BamHI fragments of 
HPV-16. The location.of these probes are presented in (II) 
and are above the respective Southern blot. The bars above 
the figures are not drawn to scale. However, in (II) the 
respective Pst I fragments are drawn to scale. 
prepared from cell lines: 
(A) R-30 (hyperplastic human fibroblasts), 
(B) 139 (R-30 cotransfected with HZIP-16 and H-ras, 
DNA was 
{C) 140 (R-30 cotransfected with HZIP-16 and HSV-2 486 TF), 
{D) 141 (R-30 cotransfected with HZIP-16 and HSV-2 Bgl II-C), 
(E) 145 (R-30 transfected with HZIP-16), 
(F) C-1 (fibroblasts from a patient treated with cyclosporin), 
(G) 181 (R-30 transfected with HZIP-16), 
(H) 227 (R-30 cotranfected with HZIP-16, H-ras), 
(I) 228 (R-30 cotransfected with HZIP-16 and H-~)-
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cell lines. 
HSV-2 DNA retention in fibroblast cell lines. The 
retention of HSV-2 DNA sequences in transformed cells was 
examined by polymerase chain reaction (PCR) • The stable 
retention of HSV-2 DNA in transformed cells has not been 
consistently observed and thus HSV-2 transformation is 
postulated to be mediated by a "hit and run" mechanism 
(reviewed by MacNab, 1987). Southern blot analysis using HSV-
2 DNA sequences as probes failed to detect HSV-2 DNA (Figure 
5). However, when high molecular weight DNA was subjected to 
PCR analysis using primers derived from 486 TF, retention of 
HSV-2 DNA was detected in three cell lines (Figure 6). All 
three had been transfected with HSV-2 DNA sequences: 1) cell 
line 140 (HZIP-16 + HSV-2 486 TF), 2) cell line 141 (HZIP-16 
+ HSV-2 Bgl II-C) and 3) cell line 268 (HZIP-16 + HSV-2 Bam 
HI-E) (Figure 6). The amplified band migrated as a 366 bp 
fragment and comigrated with the positive control (486 TF). 
In contrast, cell line 145 (HZIP-16 alone), cell lines 139 and 
227 (HZIP-16 + Ha-ras), R-30 cells and C-1 (primary gingival 
cells treated with cyclosporin) cells did not contain 
amplified products which hybridized to the 486 TF probe. 
Furthermore, the "no template" negative control lane also did 
not contain amplified products which hybridized to 486 TF. 
These results demonstrated HSV-2 DNA sequences derived from 
486 TF were retained in transformed human cells. 
Chromosome analysis of transformed cells. To examine the 
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Figure 5. Retention of HSV-2 DNA in fibroblast cell lines. , 
High molecular weight-DNA prepared from fibroblast cell lines, 
digested with Eco RI, was analyzed by Southern blot analysis 
to determine retention of HSV-2 mtr III sequences. The HSV-2 
mtr III 486 bp Pst I-Sal I fragment was used as the probe. 
Lane (A) R-30, (B) 139, (C) 140, (D) 141, (E) 145, (F) 268, 
(G) 486 TF. Size markers, lambda DNA digested with Hind III, 
are denoted by lines. 
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Figure 6. Polymerase chain reaction (PCR) analysis of 
transformed fibroblast cell lines. High molecular weight DNA 
was prepared from the respective cell lines, digested with Pst 
I and 1 ug of digested DNA used for the PCR reaction. 
Primers were derived from HSV-2 mtr III 486 TF. 
(I) Map of HSV-2 mtr III derived primers, 917 and 1262. 
(II) Southern blot analysis of PCR reaction using 486 TF as 
the probe. Lane (A) contains 0.1 ug pCPS-1 plasmid (486 TF 
cloned into Pst I and Sal I sites of pUC19). Lanes B-I 
contain DNA prepared from cell line 139 (B), cell line 140 
{C), cell line 141 (D), cell line 145 (E), cell line 227 (F), 
cell line 268 {G), R-30 cells (H), and C-1 cells (I). Lane 
(J) contains the "no template" control. Lane (K) PhiX174 DNA 
digested with Hae III (bp) and positions of these fragments 
denoted by lines (1353, 1078, 872, 603, 310, 281, 234, 174, 
and 118 bp) . 
I. 
' 1 
• 
HSV-2 mtr III Psi 1-C 
11 
prim~ 
917 
1133 
I 
Stu I 
216 bp 150 bp 
3' 
1262 
-pdmtr: 21 •mer 
Primer 917: 5' • TCACGGAGGACGACTTTGGGC • 3' 
Primer 1262: 5' - GCGTGTTCGGGGTGCTGTGGA - 3' 
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chromosomal composition of the various cell lines, karyotype 
analysis was performed. Only 50% of the cells transfected 
with HZIP-16 alone (145) were aneuploid and none of the 
aneuploid cells contained more than 100 chromosomes. However, 
90% of the cells derived from lines cotransfected with HZIP-16 
and HSV-2 DNA (140 and 141) were aneuploid (Table 3) and at 
least 25% of the cel~s had more than 100 chromosomes/cell. 
Approximately 50% of R-30 cells cotransfected with HZIP-16 and 
H-ras {139) were also aneuploid. These studies suggested that 
aneuploidy correlated with the presence of multiple 
transforming agents. 
Transformation assays. Anchorage independent growth 
capabilities of the various cell lines were analyzed to 
confirm abnormal growth characteristics. Growth was assessed 
by plating cells (PD 30-35 post-geneticin selection) in 0.3% 
agarose and scored after 10 days. Cells cotransfected with 
HZIP-16 and regions of HSV-2 mtr III sequences (140, 141 or 
268) grew more efficiently in soft agar than cells transfected 
with only HZIP-16 (145 and 181) (Table 4). Only 3% of cells 
transfected with HZIP-16 alone (cell lines 145 and 181) formed 
colonies after 10 days. However, cells cotransfected with 
HZIP-16/HSV-2 (140, 141, and 268), had more than 10% colony 
formation after 10 days. As expected, cell line 139 (HZIP-16 
and H-ras) also exhibited anchorage independent growth (after 
10 days) and R-30 cells did not grow efficiently in soft agar. 
Furthermore, saturation density of R-30 cells transfected with 
Table 3. Chromosome number per cell of the transformed cell lines. 
Cell strain 
R-30 
139 (HZIP-16/H-ras) 
140 (HZIP-16/486 TF) 
141 (HZIP-16/Bgl II-C) 
145 (HZIP-16) 
39-50 
17 
9 
2 
2 
10 
51-70 
0 
0 
0 
0 
4 
Chromosome number in a cell 
71-100 101-200 
3 0 
5 6 
13 5 
11 4 
6 0 
x > 200 
0 
0 
0 
3 
0 
Karyotype analysis of the various cell cultures was performed at PD 20 or 21 
following geneticin selection (except the parental cell R-30). The number of 
chromosomes in a population of cells was determined. 
O'I 
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Table 4. Growth characteristics of transforllled R-30 cells. 
0.3% agarose 
Cell line colony forlllation (%) 1 saturation density2 
R-30 < 1 1 X 106 ± 1 X 105 
139 (HZIP-16/H-ras) 30 4.9 X 106 ± 1.3 X 105 
140 (HZIP-16/HSV-2 486 TF) 15 ~ 5.2 X 106 ± 1.8 X 105 
141 (HZIP-16/HSV-2 Bgl II-C) 15 4.3 X 106 ± 2.0 X 105 
268 (HZIP-16/HSV-2 Bam HI-E) 15 5.1 X 106 ± 1.5 X 105 
145 (HZIP-16) 3 2.4 X 106 ± 0.6 X 105 
181 (HZIP-16) 4 2.7 X 106 ± 1.1 X 105 
The ability of R-30 cells and the various transformed derivatives of R-30 cells were 
analyzed for growth in soft agar. 
11 x 105 cells of each line were plated in medium containing 0.3% agarose and scored after 
10 days. Numbers indicate the percentage of cells which formed colonies. To be 
considered a colony, the diameter of the colony was at least 1 mm. 
2Saturation density was the number of cells/100 mm dish at confluence. Plates were seeded 
with 3 x 105 cells and the various cultures were fed three times a week. After two weeks 
in culture, the cells were trypsinized and counted using a hemacytometer. 
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HZIP-16 alone {145) was lower than cells cotransfected with 
HZIP-16/HSV-2 or HZIP-16/H-ras. When the individual cell 
lines were injected subcutaneously into nude mice {5 x 106 -
s x 106 cells/animal} , tumor formation was not readily 
observed after 6 weeks {Table 5). Transitory nodules were 
observed in animals injected with some of the transformed 
cells. However, these nodules regressed after several weeks. 
This may imply the cell lines were not fully transformed or 
the transformed cells were rejected by the mouse. In summary, 
anchorage independent growth was more efficient when R-30 
cells were cotransfected with HZIP-16 and HSV-2 DNA sequences 
or H-ras. 
Comparison of R-30 and N-16 cells. Since R-30 cells were 
immortalized more efficiently by HZIP-16 than N-16 cells, a 
comparison of the two cell types was subsequently made. No 
obvious differences were detected in morphological 
characteristics {FACS, 90° vs. forward scattering ratios), 
growth rates, or saturation densities {V. Veerisetty, 
unpublished data}. In contrast, karyotype analysis of the two 
cell types revealed that all R-30 cells have a stable 
chromosomal translocation between chromosome 8 and chromosome 
18 {Figure 7). Approximately 15% of R-30 cells contained more 
than 50 chromosomes. 
Since the c-myc protooncogene is present on chromosome 8 
{Neel et al., 1982) and alterations of this gene have been 
associated with HPV-16 and transformation {Riou et al., 1987, 
Tables. Twnorigenicity analysis of fibroblast cell lines. 
Cell line Twnor formation 
R-30 0/3 
139 (HZIP-16/H-ras) 0/3 
140 (HZIP-16/HSV-2 486 TF) 0/3 
141 (HZIP-16/HSV-2 Bgl II-C) 0/3 
145 (HZIP-16) 0/3 
268 (HZIP-16/HSV-2 Bam HI-E) 0/3 
Tumorigenic potential of fibroblast cell lines was analyzed for 
production of palpable tumors. 5 x 106 cells were injected 
subcutaneously into ,ny/nu mice. Eight weeks post injection, mice were 
anesthetized and observed for the presence of lesions. 
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Figure 7. Karyotype analysis of N-16 and R-30 cells. (I) 
Arrows indicate aberrations in chromosome 8 and 18 of R-30 
cells. All R-30 cells contained the aberrant chromosome 8 and 
18. (II) Chromosome number in a population of N-16 and R-30 
cells. The modal chromosome number for N-16 cells and R-30 
cells was 46. 
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ourst et al., 1987, Crook et al., 1990), it was important to 
examine c-myc expression and organization in R-30 cells. 
Genomic DNA was prepared from R-30 cells, R-30 derived cell 
lines or N-16 cells and southern blot analysis performed. Two 
c-myc probes, a 1.6 kb Sac I fragment of the 5'-untranslated 
region and a 420 bp Pst I fragment of exon 2, were used to 
detect aberrations in gene organization of c-myc DNA. No 
detectable rearrangements were observed in any of the R-30 
cell lines when compared to N-16 cells (Figure 8). To measure 
steady state levels of c-myc RNA expression, ribonuclease 
protection analysis was performed. An in vitro transcript was 
synthesized from the 420 bp Pst I fragment of exon 2 and used 
as a probe. As expected, a ribonuclease resistant fragment 
approximately 420 nucleotides was detected when cellular RNA 
was hybridized to an antisense c-myc transcript (Figure 9). 
R-30 cells and transformed R-30 cells clearly contained higher 
steady state levels of c-myc RNA when compared to N-16 cells 
or C-1 cells (early passage human gingival fibroblasts 
prepared from a patient treated with cyclosporin). When the 
radioactivity in the c-myc band was quantified, R-30 cells as 
well as transformed R-30 cells consistently contained at least 
three fold higher levels of c-myc RNA compared to either N-16 
or C-1 cells. These results demonstrated R-30 cells contained 
higher steady state levels of c-myc RNA and suggested the 
translocation of chromosome 8 was related to overexpression. 
Examination of the human p53 gene in fibroblast cell 
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Figure 8. c-myc gene organization in fibroblast cell lines. 
High molecular weight DNA was prepared from fibroblast cell 
lines, digested with restriction enzymes and Southern blot 
analysis was performed • Size markers, lambda DNA digested 
. 
with Hind III, are denoted by lines. 
(I) Genomic DNA was digested with Pst I and probed with the 
1.6 kb Sac I fragment of the 5'-untranslated region of c-myc. 
Lane (A) N-16, (B) R-30, (C) 139, (D) 140, (E) 141, (F) 145, 
(G) 268. 
(II) Genomic DNA was digested with Eco RI\Kpn' I and probed 
with the 420 Pst I fragment of exon 2 of c-myc. Lane (A) N-
16, (B) R-30, (C) 139, (D) 140, (E) 141, (F) 145, (G) 268. 
II 
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Figure 9. Ribonuclea~e protection analysis of N-16, c-1 and 
R-30 derived cell lines. 32P-UTP labelled RNA probes were 
synthesized from the 420 bp Pst I fragment of c-myc (exon 2). 
(A) Antisense SP6 probe contained the strand complementary to 
the c-myc mRNA coding strand while the sense T7 probe was the 
same as the coding strand. Lane (a) N-16, (b) R-30, (c) 140, 
(d) 145, (e) C-1. (B) Total cellular RNA of cell lines 
probed with B-actin. Lane (a) N-16, 
145, (e) C-1. 
(b) R-30, (c) 140, (d) 
420 ~ 
350~ 
c-Myc 
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B-actin 
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lines. The E6 oncoprotein of HPV-16/18 is able to bind and 
promote degradation of the tumor suppressor protein, p53 
(Werness et al., 1990, Scheffner et al., 1990). p53 is able 
to act as a suppressor of transformation (Eliyahu et al., 
1989, Finley et al., 1989, Hinds et al., 1989, Scheffner et 
al., 1990). To determine if human p53 (Hp53) is rearranged in 
transformed fibroblast~, organization of this tumor suppressor 
gene was examined. A ·1.5 kb Xba I-Sma I fragment of a 2.1 kb 
cDNA clone of hp53 was used as a probe. High molecular weight 
DNA was prepared from fibroblast cell lines and Southern blot 
analysis was performed (Figure 10). The Hp53 gene was 
detected in all cell lines, however, no alterations of this 
gene were detected when compared to R-30, HPV-16 immortalized 
and HPV/HSV-2 transformed. 
Generation of transformed keratinocyte cell lines. To 
study interactions between HSV-2 and HPV-16 or HPV-18 in their 
natural host, human epithelial cells, genital keratinocytes 
previously immortalized with HPVs, were transfected with 
plasmids containing HSV-2 mtr III sequences. HPV-16 (FEPL) 
and HPV-18 (FEA) immortalized cell lines were generated from 
primary human foreskin keratinocytes (Kaur and McDougall, 
1988, Kaur et al., 1989) (Figure 11). To generate HPV-16 
immortalized cell lines (FEPL) a plasmid containing the HPV-16 
E6, E7 and LCR were used to immortalized normal human 
keratinocytes (Kaur and McDougall, 1988). FEPL cells were 
subsequently utilized as parental cells in this transfection 
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Figure 10. Hp53 gene organization in fibroblast cell lines. 
(I) Schematic diagram of 2.1 kb Barn HI cDNA hp53 insert. The 
1.5 Xba I-Sma I fragment was used as the probe in all hp53 
southern blotting analysis. The 2 .1 kb Barn HI cDNA hp53 
insert was cloned into pBR322. Translational start and stop 
codons indicated by arrows. 
(II) Genomic DNA prepared from fibroblast cell lines, double 
digested with Eco RI and Xba I, was subjected to Southern 
blotting analysis. Lane (A) R-30, (B) 139, (C) 140, (D) 141, 
(E) 145, (F) C-1, (G) 181, (H) 268, (I) 1.5 kb Xba I/Sma I 
hp53 fragment. The probe used for hybridization was the 1.5 kb 
hp53 fragment. Size markers, lambda DNA digested with Hind 
III are denoted by lines. 
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Figure 11. Schematic map of HPV-16 and HPV-18. 
(I) Map of HPV-16 inpicating the 3.4 kb fragment of HPV-16 
DNA retained in a tumor clone (black boxes) used to 
immortalize primary genital keratinocytes (Kaur et al, 1989). 
These HPV-16 immortalized keratinocytes were subsequently used 
to generate HSV-2/HPV-16 cell lines (designated as FEPL-
cells). Restriction enzyme sites are K (Kpn I), H (Hine II), 
S (Stu I), E (Eco RI) and B (Barn HI). 
(II) Restriction map of HPV-18. pHPV18, containing HPV-18 
genome and pBR322 vector sequences, was used to transfect 
primary genital keratinocytes (Kaur and McDougall, 1988). The 
resulting HPV-18 immortalized cell lines were used to generate 
HSV-2/HPV-18 cell lines (designated as FEA- cells). 
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analysis. HPV-18 immortalized (FEA) cells were generated by 
cotransfecting primary human epithelial cells with a plasmid 
containing the entire HPV-18 genome and pSV2neo and selecting 
for growth in geneticin (Kaur and McDougall, 1988). FEA cells 
were also used as parental cells in this analysis. Both cell 
lines were maintained in culture over one year prior to these 
studies. 
To test for morphological transformation of FEPL and FEA 
cells, plasmids containing HSV-2 DNA sequences derived from 
mtr III (Jones et al., 1986) were transfected into parental 
cell lines. Additionally, a plasmid containing an activated 
H-ras gene, pEJ6. 6, was transf ected into immortalized cells to 
serve as a positive control for cooperation with HPVs 
(Matlashewski et al., 1987). Table 6 shows the results from 
the transfection experiments using HPV-16 (FEPL) and HPV-18 
(FEA) immortalized cells. Three independent experiments were 
performed. G418 selection was utilized because parental HPV-
immortalized cells have lost their geneticin resistance and 
thus are sensitive to drug selection. Stable cell lines were 
obtained with all transfectants. FEPL and FEA cells had 
similar transfection efficiencies. No single HSV-2 mtr III 
region was more efficient for transforming either FEPL or FEA 
cells. The overall efficiency of Experiment 1 from Table 6 
was low compared to subsequent experiments. In summary, 
results demonstrated that geneticin resistant cell lines could 
be obtained from HPV immortalized cells transfected with HSV-2 
Table 6. 'Rransfection analysis of illllortalize4 keratinocytes. 
HSV-2 486TF 
HSV-2 Pst I-C 
HSV-2 Bam HI-E 
Ha-ras 
pSV2neo 
FEA (RPV-18) 
Exp. 1 Exp. 2 Exp. 3 
2 
1 
1 
3 
0 
5 
5 
8 
4 
2 
8 
6 
6 
9 
4 
FEPL (RPV-16) 
Exp. 1 Exp. 2 Exp. 3 
0 
1 
1 
0 
0 
7 
6 
7 
8 
5 
10 
8 
12 
15 
10 
HPV-16 or -18 immortalized genital keratinocytes (5 x 105 cells/60 mm dish) were 
transfected with 10 ug plasmid DNA using the polybrene transfection procedure (Rhim 
et al, 1986) followed by geneticin selection (50 ug/ml for FEA cells, 500 ug/ml for 
FEPL cells). Values indicate the number of geneticin resistant colonies. 
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mtr III derived sequences. 
Growth characteristics of transformed cell lines. A 
comparison of HPV immortalized and HPV/HSV-2 transformed cell 
lines was undertaken to determine if differences existed. 
subtle morphological differences between HPV-16 immortalized 
and HPV-16/HSV-2 transformed keratinocytes were observed 
(Figure 12). Transfor~ed cells were irregularly shaped, less 
organized compared no immortalized cells. Furthermore, 
morphological differences were seen between primary 
keratinocytes and an immortalized FEPL clone in Figure 13. 
Differences were more apparent in transformed FEPL cells than 
FEA cells. Saturation density analysis indicated that FEPL or 
FEA cells transformed by mtr III DNA fragments contained two 
times the number of cells after one week in culture than the 
immortalized counterpart (Table 7) • HPV /H-ras cell lines (FEA 
or FEPL) behaved similarly to HPV/HSV-2 transformants while 
HPV immortalized cells with pSV2neo had saturation density 
values similar to the HPV immortalized parental cells. 
To analyze anchorage independent growth capabilities of 
the various cell lines, growth was assessed by plating cells 
in 0.3% agarose and scoring after 10 days. All three HPV-
16/HSV-2 transformed cell lines grew at similar efficiencies 
in soft agar. Immortalized FEPL cells were able to grow with 
low efficiency in soft agar, however, not at the rate of the 
transformed counterparts. In contrast, the HPV-18/HSV-2 
transformed cells did not grow in soft agar. Furthermore, FEA 
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Figure 12. Photograph.of immortalized FEPL cells (I) and FEPL 
cells transformed with the HSV-2 mtr III Bam HI-E fragment 
(II) . 
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Figure 13. Primary keratinocytes immortalized with HPV-16. 
Photograph of immortalized HPV-16 geneticin resistent colony 
seen along with primary keratinocytes. 
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Table 7. Growth characteristics of keratinocyte cell lines. 
Cell line 
0.3% agarose 
colony fomtion1 saturation density2 
FEA-N (HPV-18) < 1 1. 2 X 106 ± 6. 5 X 105 
ATF-1 (HPV-18/486 TF) < 1 2. 8 X 106 ± 4. 4 X 105 
APC-1 (HPV-18/Pst I-C) < 1 2 . 0 X 106 ± 8 . 8 X 105 
. 
. 
ABE-1 (HPV-18/Bam HI-E) < 1 2. 6 X 106 ± 6. 3 X 105 
FEPL-N (HPV-16) 5 3. 2 X 106 ± 8. 7 X 105 
PTF-1 (HPV-16/486 TF) 15 6 . 3 X 106 ± 3 • 8 X 105 
PPC-1 (HPV-16/Pst I-C) 15 5 • 9 X 106 ± 5 • 8 X 105 
PBE-1 (HPV-16/Bam HI-E) 15 6.4 X 106 ± 4.5 X 105 
Growth characteristics of keratinocyte cell lines were analyzed for anchorage 
independent growth and saturation density rates. 
11 x 105 cells of each cell line were plated in medium containing 0.3% agarose and 
scored after 10 days. Numbers indicate the approximate percentage of cells which 
formed colonies. Colonies were counted if size was at least 1 mm. 
2Saturation density was the number of cells/100 mm dish at confluence. Plates were 
seeded with 3 x 105 cells and after one week in culture, cells were trypsinized and 
counted using a hemocytometer. 
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illlillortalized cells did not grow efficiently in soft agar 
(Table 7). In summary, slight differences in morphology were 
detected in HPV-16/HSV-2 transformed cell lines but these 
differences were not readily seen in HPV-18/HSV-2 cell lines. 
Morphology changes were clearly apparent after primary 
keratinocytes were immortalized with HPVs. Both HPV-16 and 
HPV-18 transformed cell lines had saturation density values 
twice as great as their immortalized counterpart. Only HPV-
16/HSV-2 transformed cells exhibited anchorage independent 
growth capabilities. 
HPV DNA retention in keratinocyte cell lines. FEA and 
FEPL cell lines have one to two copies of integrated viral 
genomes/cell (Kaur and McDougall, 1988, Kaur et al., 1989). 
This study was conducted to examine the organization of HPV 
DNA after the cells were transformed by HSV-2 mtr III or H-
ras. High molecular weight DNA from various cell lines was 
analyzed to detect rearrangments of HPV viral DNA by Southern 
blot analysis. 
Genomic DNA from FEPL cell lines, containing only 3.4 kb 
of HPV-16 sequences, was hybridized to three separate probes: 
a large 6.6 kb probe spanning the entire HPV-16 early genome 
(excised from HZIP-16, does not include the late region), a 
1. 0 kb probe covering the LCR, E6 and E7 ORFs (Pst I-B 
fragment of HPV-16) and a 2.6 kb probe containing the El, E2 
ORFs (Kpn I/Hine II fragment of HPV-16). Two HPV-16 specific 
fragments were detected when Pst I digested genomic DNA was 
probed with the 6. 6 kb HPV-16 probe (Figure 14). 
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Pst I 
digestion of 3.4 kb HPV-16 sequences retained in FEPL cells 
yields 4 fragments: 2 which contain the early HPV-16 regions 
and 2 which span the late HPV-16 regions. The latter two 
bands would not be detected with the 6. 6 kb probe. These 
results suggest the early region of the 3.4 kb sequence is 
intact. Hybridizatioq with the 6.6 kb probe did not show any 
rearrangments of the HPV-16 genome. Neither the 1.0 kb Pst I-
B (Figure 15) nor the 2.8 kb Kpn I-A (Figure 16) revealed any 
rearrangements of the HPV-16 DNA in transformed cell lines. 
Malignant lesions which contain HPV DNA integrated into the 
cellular genome frequently have only a portion of the viral 
DNA present (Durst et al., 1985). Viral DNA usually consists 
of an intact E6, E7 and LCR (Matsukura et al., 1986, Pater and 
Pater, 1985, Seedorf et al., 1987). The Kpn I-A probe was 
utilized to detect possible rearrangments of viral DNA since 
HPV integration occurs within the El/E2 ORFs and alterations 
generally occur in this region. However, no rearrangments of 
HPV-16 DNA were detected in the transformed cell lines, 
although, changes in the E6 and E7 genes of HPV would not be 
expected to occur. 
To determine if rearrangements of the HPV-18 DNA were 
present in transf armed cells, Southern blot analysis was 
performed. High molecular weight DNA prepared from FEA 
derived keratinocyte cell lines was hybridized to a 7.9 kb 
HPV-18 probe, spanning the entire genome of HPV-18. Figure 17 
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Figure 14. Organization of HPV-16 DNA in FEPL-derived cell 
lines. High molecular weight DNA was prepared from FEPL-
derived cell lines, digested with Pst I and Southern blot 
analysis was performed. DNA was probed with the 6.6 kb Barn HI 
HPV-16 insert of HZIP-16. Lane {A) FEPL-N, (B) PTF-2, {C) 
PPC-1, (D) PPC-2, (E) PBE-2, {F) Pneo, (G) 6.6 kb HPV-16 Barn 
HI fragment. size markers, lambda DNA digested with Hind III, 
are denoted by lines. 
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Figure 15. Retention of E6, E7 ORFs in FEPL cell lines. High 
molecular DNA prepared.from FEPL derived cell lines was double 
digested with Pst I and Eco RI and subjected to southern blot 
analysis. DNA was probed with the Pst I-B fragment of HPV-16 
which spans, ORFs E6, E7 and the LCR. Lanes (A) FEPL-N, (B) 
PTF-2, (C) PPC-1 (D) PPC-2, (E) PBE-1, (F) Pras. Size 
markers, lambda digested with Hind III, are denoted by bars. 
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Figure 16. Retention of ORF El in FEPL cell lines. Genomic 
DNA was prepared from FEPL derived cell lines, double digested 
. 
with Pst I and Eco RI and Southern blot analysis was 
performed. The 2.8 kb Kpn I-A fragment, spanning the entire 
El ORF was used the probe. Lane (A) FEPL-N, (B) PTF-2, (C) 
PPC-1, (D) PPC-2, (E) PBE-1, (F) Pras. Size markers, lambda 
DNA digested with Hind III, are denoted by lines. 
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Figure 17. Rearra~gment of HPV-18 DNA in transformed 
keratinocyte cell lines. Genomic DNA prepared from FEA-
derived cell lines, digested with Pst I, was subjected to 
Southern blotting. The 7.9 kb HPV-18 genome was utilized as 
the probe. Lane (A) FEA-N, (B) ATF-1, (C) ATF-2, (D) APC-1, 
(E) ABE-1, (F) ABE-2, (G) Aras, (H) Aneo, (I) 7.9 kb fragment 
of HPV-18. Size markers, lambda DNA digested Hind III, are 
designated by lines. 
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shows the results of the Southern blot analysis. 
Rearrangements of viral DNA were detected in transformed cells 
(lanes B-F) when compared to immortalized (lane A) and HPV/H-
ra.§. (lane G) cell lines. Deletions were detected in 
transformed cells with the loss of a 2.3 kb band in APC-1 
(lane D) and ABE-1 (lane F). In contrast, cell line APC-2 
contained an additionai 2.6 kb hybridizing fragment (lane E). 
similar results were seen when genomic DNA was digested with 
Hine II (Figure 18). However, when genomic DNA of FEA cell 
lines was hybridized to a HPV-18 probe spanning E6, E7 and 
LCR, no changes were detected (Figure 19) as expected since 
this region remains intact in a majority of HPV-18 cell lines. 
In summary, no detectable changes were present in the HPV-16 
DNA of transformed cell lines. However, rearrangments were 
detected in the HPV-18 DNA after FEA cells were transformed by 
HSV-2 mtr III sequences. 
Retention of HSV-2 DNA sequences in transformed cell 
lines. HSV-2 DNA sequences have not consistently been 
detected in transformed cells, however, significant evidence 
has demonstrated a correlation between HSV-2 infection and 
malignant transformation (DiLuca et al., 1989, Hildesheim et 
al., 1991). The inconsistent nature of HSV-2 DNA retention 
has led to a "hit and run" hypothesis for HSV-2 mediated 
transformation (reviewed by MacNab, 1987). Southern blot 
analysis using HSV-2 DNA sequences as probes failed to detect 
viral DNA (Figure 20) . Since PCR analysis is a more sensitive 
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Figure 18. Hine II digest of DNA from FEA-derived cell lines. 
Genomic DNA was prepared from FEA-derived cell lines, digested 
with Hine II and subjected to Southern blotting. Lane (A) 
FEA-N, (B) ATF-1, (C) ATF-2, (D) APC-1, (E) APC-2, (F) ABE-1, 
(G) ABE-2, (H) Aras. The probe used was the 7.9 kb HPV-18 
genome. Molecular size markers, lambda DNA digested with Hind 
III, are denoted by lines. 
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Figure 19. Retention of HPV-18 sequences in keratinocyte cell 
lines. High molecular weight DNA prepared from HPV-18 
keratinocyte cell lines, digested with Pst I, was subjected to 
southern blotting analysis. A 2. 4 Eco RI/Bgl I fragment 
spanning the HPV-18 LCR, E6, E7 ORFs. Lane (A) FEA-N, (B) 
ATF-1, (C) ATF-2, (D) APC-1, (E) APC-2, (F) ABE-1, (G) Aras. 
Size markers, lambda DNA digested with Hind III, are denoted 
by lines. 
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Figure 20. Retention of HSV-2 DNA sequences in PEA-derived 
,, 
cell lines. High mo].ecular weight DNA prepared from FEA 
derived keratinocyte cell lines, digested with Eco RI, was 
analyzed by Southern blot analysis to detect retention of HSV-
2 DNA sequences. The HSV-2 mtr III 486 bp Pst I-Sal I 
fragment (486 TF) was used as the probe. Lane (A) FEA-N, (B) 
ATF-1, (C) ATF-2, (D) APC-1, (E) APC-2, (F) ABE-1, (G) Aras, 
(H) Aneo, (I) 486 TF. Molecular size markers, lambda DNA 
digested with Hind III, are denoted by bars. 
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assay to detect DNA sequences present in very low quantities, 
this technique was employed. High molecular weight DNA 
digested with Eco RI was subjected to PCR analysis using 
primers derived from HSV-2 486 TF. Analysis of FEPL and FEA 
derived cell lines indicated HSV-2 retention in only three FEA 
cell lines {Figure 21). None of the 5 HPV-16/HSV-2 cell lines 
retained HSV-2 DNA, whereas, 
• 
3/5 HPV-18/HSV-2 cell lines 
retained HSV-2 DNA sequences, ATF-2, APC-2, ABE-2. The 
amplified band migrated as a 366 bp fragment. Neither the 
immortalized keratinocyte cell lines, normal keratinocyte DNA 
nor the HPV/H-ras had 486 TF hybridizing fragments. These 
results demonstrated HSV-2 DNA sequences were present in low 
concentrations in some transformed cell lines. 
Analysis of cellular protooncogene c-myc in transformed· 
keratinocyte cell lines. Earlier studies have demonstrated 
that integration of high risk HPVs occurs near the c-myc 
protooncogene or led to disruption of c-myc gene {Riou et al., 
1987, Durst et al., 1987, Crook et al., 1990). To determine 
if the c-myc locus was disrupted after FEA or FEPL cells were 
transformed by HSV-2 mtr III, organization of the c-myc gene 
was examined. Two c-myc probes, a 1.6 kb Sac I fragment of 
the 5' untranslated region and a 420 bp Pst I fragment of exon 
2 were utilized to detect alterations in gene organization of 
c-myc DNA. Figures 22 and 23 show t~e Southern blot results 
when high molecular weight DNA was digested with restriction 
enzymes {HPV-16, Pst I; HPV-18, Hine II) and hybridized to the 
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Figure 21. Polymerase chain reaction (PCR) analysis of 
transformed keratinocy~e cell lines. High molecular weight 
DNA was prepared from the respective cell lines, digested with 
Pst I and 1 ug of digested DNA was used for the PCR reaction. 
Primers were derived from HSV-2 mtr III 486 TF. Lane (A) 
contains 0.1 ug pCPS plasmid (486 TF cloned into Pst I and Sal 
I sites of pUC19). Lanes B-Q contains DNA prepared from FEPL 
and FEA derived cell lines. Lane (B) PTF-1, (C) PPC-1, (D) 
PPC-2, (E) PBE-1, (F) PBE-2, (G) Pras, (H) Pneo, (I) ATF-2, 
(J) APC-1, (K) APC-2, (L) ABE-1, (M) ABE-2, (N) Aras, (0) 
Aneo, (P) normal primary keratinocyte DNA, (Q) "no template" 
control. The probe used was the 486 TF fragment. Bars 
indicate size markers, PhiX174 DNA digested with Hae III (bp) 
(1353, 1078, 872, 603, 310, 281, 234, 174, and 118). 
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Figure 22. c-myc gene organization in FEPL-derived cell 
lines. High molecul~r weight DNA from FEPL cell lines was 
prepared and digested with Eco RI and Pst I, followed by 
Southern blotting analysis. Lanes (A) FEPL-N, (B) PTF-2, (C) 
PPC-1, (D) PPC-2, (E) PBE-2, (F) Pneo, (G) either 5'-
untranslated region (I) or exon 2 in (II). Probes used in 
hybridization were (I) a 1.6 kb Sac I fragment of the 5 1 -
untranslated region and (II) a 420 bp Pst I fragment of exon 
2. Size markers, lambda DNA digested with Hind III, are 
denoted by lines. 
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Figure 23. c-myc gene organization in FEA-derived cell lines. 
High molecular weight DNA was prepared from primary 
keratinocytes and FEA derived . cell lines, digested with 
restriction enzymes, and Southern blot analysis was performed. 
Size markers, lambda DNA digested with Hind III, are denoted 
by lines. 
(I) Genomic DNA was digested with Pst I and probed with the 
1.6 kb Sac I fragment of the 5'-untranslated region of c-myc. 
Lane (A) normal primary keratinocyte DNA (NKD), (B) FEA-N, (C) 
ATF-1, (D) ATF-2, (E) APC-2, (F) ABE-1, (G) ABE-2, (H) Aras. 
(II) Genomic DNA was digested with Hine II and probed with 
the 420 bp Pst I fragment of exon 2 of c-myc. Lane (A) NKD, 
(B) FEA-N, (C) ATF-1, (D) ATF-2, (E) APC-2, (F) ABE-1, (G) 
ABE-2, (H) Aras. 
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c-myc probes. No detectable rearrangments were observed in 
any cell lines, either HPV-16 or HPV-18 derived. Furthermore, 
c-myc organization of immortalized and transformed cell lines 
was compared to primary keratinocyte DNA and no changes were 
apparent. Multiple restriction digests (Eco RI, Eco RI/Pst I, 
Eco RI/Kpn I) were anaylzed. 
Analysis of hp53 in transformed keratincyte cell lines • 
• 
Mutations in the tumor suppressor gene, p53, have been 
associated with hyperproliferation and chromosomal instability 
(Hudson et al., 1990, Woodworth et al., 1990). The E6 early 
protein of HPV-16/18 binds the p53 gene product and promotes 
degradation of the cellular protein (Scheffner et al., 1990). 
Thus, it was of interest to understand what role this cellular 
gene may have in the pathogenesis of HPV/HSV-2 transformed 
cell lines. Hence, gene organization of human p53 (hp53) was 
analyzed. A 1.5 kb Xba I-Sma I fragment from the hp53 cDNA 
clone was used as probe since it yielded clear results. 
Southern blot analysis indicated no apparent aberration in 
hp53 gene organization of either FEPL derived (Figure 24) or 
FEA derived (Figure 25) cell lines. Multiple digests of 
genomic DNAs were performed and did not detect rearrangments 
(data not shown) • In summary, rearrangements of the hp53 
tumor suppressor gene were not apparent in HPV/HSV-2 
transformed cell lines when compared to HPV immortalized cell 
lines. 
RNA analysis of transformed cell lines. Northern blot 
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Figure 24. Hp53 gene organization in FEPL-derived cell lines. 
1 
Genomic DNA was prepar~d from FEPL derived cell lines, double 
digested with Eco RI and Pst I and Southen blot analysis was 
performed. The probe used for hybridization was the 1.5 kb 
Xba I-Sma I fragment of hp53. Lane (A) FEPL-N, (B) PTF-2, (C) 
PPC-1, (D) PPC-2, (E) PBE-2, (F) Pneo, (G) hp53 probe. Size 
markers, lambda DNA digested with Hind III, are denoted by 
lines. 
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Figure 25. Hp53 gene organization in FEA-derived cell lines. 
' Southern blotting analysis was performed using genomic DNA 
prepared from FEA cell lines and digested with Pst I. DNA was 
probed with the 1. 5 kb Xba I-Sma I fragment of hp53. Lane (A) 
FEA-N, (B) ATF-1, (C) ATF-2, (D) APC-1, (E) APC-2, (F) ABE-1, 
(G) Aras, (H) Aneo. Molecular size markers, lambda DNA 
digested with Hind III, are denoted by lines. 
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analysis was performed to determine if RNA transcripts 
differed in HPV immortalized and HPV/HSV-2 transformed cell 
lines. Total cellular RNA was hybridized to probes spanning 
the HPV-16 or -18 E6 and E7 ORFs. Three transcripts were 
detected ranging in size from 4.5 kb to 1.8 kb (Figure 26). 
However, no specific differences were observed between 
immortalized and transformed cell lines • 
• 
Tumorigenicity analysis. To determine if the respective 
cell lines could induce tumors in animals, cell lines were 
injected subcutaneously into nu/nu nude mice ( 5 x 106 
cells/animal). Mice were monitored weekly for the presence of 
lesions. Eight weeks post injection, mice were anesthesized 
and lesions excised. FEPL (HPV-16) cells transfected with 
HSV-2 mtr III sequences were all able to form abnormal tumor-
like epithelial lesions (Table 8), in contrast to HPV-16 
immortalized cells. FEPL cells transfected with H-ras also 
formed tumor-like lesions however, they were not invasive, as 
Matlashewski et al., (1987) had demonstrated with rodent 
cells. Histological analysis of tumor-like lesions with HPV-
16/HSV-2 mtr III sequences indicated benign epithelial cysts. 
Typically these tumor-like lesions were present 4 weeks post 
injection. 
FEA (HPV-18) cells were unable to produce any lesions. 
Tumor formation in mice injected with HPV-18/HSV-2 mtr III 
cell lines was not readily observed 8 weeks post injection. 
Lesions were not observed even in FEA cells transfected with 
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Figure 26. HPV expression in transformed keratinocytes. 
Total cellular RNA was extracted from keratinocyte cell lines 
using the guanidine thiocyanate/cesium chloride method and 
subjected to Northern blot analysis. Ten ug of total RNA was 
loaded per lane in a~% formaldehyde gel. In (I), (II), and 
(III), lane (A) FEPL-N, (B) PPC-1, {C) PTF-1, (D) FEA-N, (E) 
APC-2, (F) ATF-2. 28S and 18S ribosomal RNA markers are 
shown. 
(I) Northern blot analysis of FEPL- cells (HPV-16) and FEA-
cells (HPV-18). The HPV probe used was derived from HPV-16, 
the Baro HI-Pst I fragment covering E6, E7 and LCR. 
(II) Northern blot analysis FEPL- and FEA- cell lines. The 
HPV probe used was derived from HPV-18, the Baro HI-Eco RI 
fragment covering E6, E7, LCR and 2/3 of El. 
(III) Northern blot analysis of FEPL- and FEA- cells using 
actin as a probe to ensure equal levels of RNA were loaded in 
each lane. 
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Table a. Tumorigenicity analysis of keratinocyte ce11 1ines. 
Cell Line 
FEPL-N (HPV-16) 
PTF-1 (HPV-16/486 TF) 
PPC-1 (HPV-16/Pst I-C) 
PBE-1 (HPV-18/Bam HI-E) 
Pras (HPV-16/H-ras) 
FEA-N (HPV-18) 
ATF-2 (HPV-18/486 TF) 
APC-2 (HPV-18/Pst I-C) 
ABE-2 (HPV-18/Bam HI-E 
Aras (HPV-18/H-ras) 
Hela (HPV-18 cervical 
carcinoma) 
Tumor Formation 
0/5 
2/5 
5/7 
4/5 
4/5 
0/5 
0/5 
0/5 
0/5 
0/5 
2/2 
Type of Lesion 
epithelial cyst 
epithelial cyst 
epithelial cyst 
epithelial cyst 
anaplastic 
carcinoma 
Tumorigenic potential of keratinocyte cell lines was analyzed for production of 
palpable tumors. 5 x 106 cells were injected subcutaneously into nu/nu mice. Eight 
weeks post injection, mice were anesthetized and observed for the presence of 
lesions. Lesions were classified based on histological analysis. 
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H-ras. However, when Hela cells, HPV-18 containing cervical 
carcinoma cell line, were injected into nude mice, tumors 
appeared after two weeks and grew progressively. Histological 
analysis of Hela lesions indicated anaplastic carcinoma. 
Figure 27 shows the tumor-like lesions seen upon injection of 
HPV-16/HSV-2 Pst I-C cells into mice. These tumor-like 
lesions were similar with other HSV-2 mtr III sequences. 
1 
Figure 28 demonstrates the histological analysis of normal 
adjacent tissue (muscle) (I), tumor-like lesions (II), and 
Hela induced anaplastic carcinoma (III, IV). The tumor-like 
epithelial lesions formed circular cysts. These contained 
actively growing, keratin producing cells able to enlarge the 
lesion with time. Histological analysis of the Hela induced 
tumor showed characteristics indicative of an invasive 
carcinoma. Numerous multinucleated cells, abnormal mitotic 
phases were visible along with necrotic cells near the 
invasive cells. Figure 29 shows the gross anatomy of the Hela 
infected mouse, enlarged area of tumor formation and size of 
tumor. In summary, HPV-16/HSV-2 cell lines were able to form 
benign epithelial cysts when injected into nude mice in 
contrast to HPV-18/HSV-2 cell lines where lesions were not 
readily apparent. This may imply a propensity for HPV-16, 
more commonly found in cervical carcinoma biopsies than HPV-
18, to interact with transforming agents such as H-ras and 
HSV-2 mtr III sequences in the induction of tumor-like 
epithelial lesions. In addition, the inability of HPV-18/HSV-
118 
2 or H-ras to produce lesions may indicate rejection of these 
human cells by the mouse. 
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Figure 27. Photograph of HPV-16/HSV-2 induced epithelial 
cyst. Arrows indicate tumor-like lesion observed after 8 
weeks post injection of 5 x 106 HPV-16/HSV-2 Pst I-C cells 
into nu/nu mouse. The tumor-like lesion was small and white. 
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Figure 28. Histological analysis of (I) normal muscle tissue, 
(II) tissue from the tumor-like lesion induced by HPV-16/HSV-2 
Pst I-C cells, (III) tissue from Hela induced anaplastic 
carcinoma. Arrows indicate invasive cells. (IV) 
Magnification of Hela tumor showing multinucleate cells and 
abnormal mitotic phases. 
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Figure 29. Gross anatomy of Hela induced tumor. (I) 5 x 106 
cells were injected subcutaneously into nu/nu mice. Arrow 
indicates large tumor observed 8 weeks post injection. (II) 
Mice were anesthesized 8 weeks post injection and the tumor 
was excised. (III) Photograph of anaplastic tumor excised 
from nu/nu mouse injected with Hela cells, a cervical 
carcinoma. 
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DISCUSSION 
In this study, cell lines were established from primary 
human cells transfected with viral DNA constructs from two 
human DNA tumor viruses, herpes simplex virus 2 and human 
papillomavirus types 16/18. Characterization of resulting 
cell lines was performed to determine if viral DNAs act in 
synergy to morphologically transform primary human cells. 
Human fibroblasts and keratinocytes were utilized in the 
analysis. Studies demonstrated that transformed cell lines 
with both HSV-2 and HPV-16 or 18 had a distinct phenotype when 
compared to HPV immortalized cells. Transformed cell lines 
were morphologically distinct, able to grow to higher 
saturation densities, exhibited anchorage independent growth 
capabilities, and were able to produce lesions in athymic mice 
in contrast to their HPV immortalized counterpart. 
CHARACTERIZATION OF HUMAN FIBROBLAST CELL LINES. 
Gingival fibroblasts were obtained from a· (1) normal 
indi;vidual and (2) from an epileptic patient treated with 
phenytoin, an anti-seizure drug (Delgado-Escueta et al., 
1983) • Phenytoin treatment of epileptic patients clearly 
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leads to hyperplastic gingival growth (Hassel et al., 1983) 
and may be related to an increased incidence of pseudolymphoma 
syndrome and Hodgkin's disease (reviewed in Wolf et al., 
1985). Apart from these observations, little is known 
concerning the deleterious side effects of prolonged use of 
phenytoin. Fibroblast cell lines were derived from gingival 
tissue. 
Early passage human cells were cotransfected with 
plasmids containing HPV-16 and HSV-2 DNA sequences derived 
from mtr III or the H-ras oncogene. These studies 
demonstrated that a plasmid containing the early genes of HPV-
16 could efficiently immortalize gingival cells derived from 
hyperplastic tissue (R-30) but not gingival cells derived from 
a normal individual (N-16) (Table 1). Neither the H-ras 
oncogene nor various fragments derived from HSV-2 mtr III 
alone were capable of immortalizing R-30 or N-16 cells. 
Although the HSV-2 Bgl II-C fragment is capable of fully 
transforming primary Syrian hamster cells (Jariwalla et al, 
1983), it did not immortalize R-30 cells by itself. This 
suggests that requirements for immortalizing human cells are 
unique with respect to primary rodent cells. Cell lines 
containing HPV-16 and H-ras or HSV-2 DNA sequences, grew more 
efficiently in soft agar, had a higher saturation density, and 
were more aneuploid when compared to R-30 cells or R-30 cells 
immortalized by HPV-16. 
The finding that HPV-16 was able to immortalize the 
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hyperplastic R-30 cells more efficiently than N-16 cells 
implied R-30 cells are predisposed toward malignant 
transformation. It is tempting to speculate that the 
chromosomal translocation in R-30 cells and overexpression of 
c-myc plays a role in efficient immortalization by HPV-16. 
Southern blot analysis using two c-myc probes ( 5' -untranslated 
region and a portion of exon 2) showed no major differences in 
c-myc DNA organization (Figure 8) • However, c-myc gene 
expression in R-30 cells and R-30 derived cell lines was 2-3 
fold higher when compared to other low passage human gingival 
cell lines (N-16 or C-1) (Figure 9). Furthermore, N-16 or C-1 
cell strains do not contain obvious chromosomal aberrations. 
Integration of papillomavirus sequences near the c-myc locus 
has been hypothesized to play a role in viral transformation 
(Durst et al., 1987) and as such c-myc appears to play a role 
in HPV induced transformation. Although c-myc is slightly 
overexpressed in R-30 cells, the increased levels of c-myc was 
apparently not sufficient to allow H-ras to transform R-30 
cells as described using cotransfection experiments with an 
activated c-mYQ and H-ras (Land et al., 1983, Parada et al., 
1984). It is not known if the chromosomal translocation in R-
30 cells is a common result of phenytoin treatment. Thus, it 
appears cellular factors can play a crucial role in the 
efficiency of HZIP-16 induced immortalization of early passage 
human cells. 
All fibroblast cell lines cotransfected with HZIP-16 
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retained HPV-16 DNA sequences as judged by Southern blotting. 
Viral DNA was integrated into the cellular genome since HPV-16 
sequences hybridized to the high molecular weight DNA of 
genomic DNA not digested with restriction enzymes (Figures 2, 
3) • HPV-16 or 18 DNA is usually integrated in malignant 
lesions in vivo (Durst et al., 1985) and in this respect, the 
fibroblast cell lines are similar to in yiyQ findings. 
Although all cell lines retained HPV-16 DNA, the number of 
copies of viral DNA/cell varied dramatically among the various 
cell lines. Cell line 140 and 145 contained similar levels of 
HPV-16 DNA while cell line 141 and 139 had approximately 
equivalent amounts (Figure 2) suggesting a random pattern for 
viral integration into the cellular genome. Random 
integration of HPV DNA in cervical carcinoma is generally the 
rule (Durst et al., 1983, Baker et al., 1987). When high 
molecular weight DNA of fibroblast cell lines was analyzed to 
map which regions of the HPV-16 genome were retained, the 
entire genome was retained. The presence of multiple bands 
which do not migrate with control Pst I probes (Figure 4) 
indicated integration of viral DNA with cellular DNA and 
duplications of the HPV-16 genome during transformation. As 
observed in tissue from cervical cancer, HPV-16 DNA is 
integrated into the cellular genome in random positions and 
frequently undergoes duplications or amplification (Wagatsuma 
et al., 1990). 
HSV-2 DNA sequences derived from mtr III were present in· 
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3/3 cell lines cotransfected with HZIP-16 and mtr III 
containing plasmids (cell lines 140, 141, and 268; Figure 6). 
These results suggested retention of HSV-2 DNA sequences may 
lead to growth in soft agar of transformed cells compared to 
R-30 cells immortalized with HZIP-16 alone (Table 4). HSV-2 
DNA retention was not observed when Southern blotting analysis 
was performed. However, when the more sensitive PCR assay was 
employed, HSV-2 mtr III specific DNA was detected, suggesting 
the presence of HSV-2 DNA correlated with very low number of 
viral copies. The low copy level of HSV-2 DNA may be a result 
of the excision of viral sequences during replication. HSV-2 
has been hypothesized to transform cells by a "hit and run" 
mechanism where viral sequences are required for 
transformation but not for the maintenence of the transformed 
phenotype (Skinner, 1976, Galloway and McDougall, 1983). It 
is not clear if HSV-2 DNA sequences are integrated or persist 
as an episome in these cells, however, these cells have 
undergone extensive passage (at least 80 PD post geneticin 
selection) prior to PCR analysis. 
Several models have been proposed alluding to the role 
played by tumor suppressor genes in human cancer (Knudson, 
1985, stanbridge, 1990). The E6 and E7 proteins of high risk 
HPVs (types 16 and 18) interact with cellular tumor suppressor 
proteins: retinoblastoma with E7 and p53 with E6. An analysis 
of HPV positive and negative cervical carcinomas revealed HPV 
positive cancers had relatively low levels of hp53 protein and 
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an intact hp53 gene (Scheffner et al., 1991) suggesting an 
intact protein was required to interact with the HPV E6 
protein. DNA from fibroblast cell lines indicated no 
rearrangments of the hp53 gene organization when compared to 
DNA from R-30 cells (Figure 10). This result is similar to 
HPV-positive carcinomas where the hp53 gene is not mutated and 
thus may be able to produce an intact protein which interacts 
with the HPV E6 protein. 
Hyperplastic R-30 cells are a unique model to study 
multistep carcinogenesis since they do not behave as a typical 
immortalized cell line. This conclusion was based on the fact 
that H-1:ll alone or HSV-2 transforming fragments were unable 
to stably transform R-30 cells (Table 1). Several studies 
have demonstrated that H-ras can transform established or 
immortalized cells but not primary human or rodent cells 
(Sager et al., 1983, Barbacid, 1987 references therein). When 
H-ras or HSV-2 DNA fragments were cotransfected with HZIP-16, 
the resulting cell lines were distinct compared to cells 
immortalized by HZIP-16. For instance, cotransfection of 
HZIP-16 with H-ras or HSV-2 DNA sequences consistently led to 
a higher degree of aneuploidy and these cells also grew better 
in soft agar when compared to HZIP-16 immortalized R-30 cells 
(Tables 3, 4). 
Although R-30 cells are not immortalized, they may not 
truly be a primary cell. This cell strain may represent a 
stage in which a cell has undergone an alteration, a "single 
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hit", which can allow for subsequent assaults on its 
phenotype. Thus, phenytoin treatment of R-30 cells and 
resulting hyperplasia may have resulted in the phenotypic 
change of its cellular makeup which may allow for further 
alterations to occur. 
colorectal cancer has 
Extensive genetic analysis of human 
demonstrated that multiple tumor 
progression events occur during carcinoma. There are a number 
of alterations the cells undergo from activation of oncogenes 
to inactivation of tumor suppressor genes (Vogelstein et al., 
1988, Stanbridge, 1990, Fearon and Vogelstein, 1990). By 
employing a normal primary cell strain and a primary-like cell 
strain in this study, one may be able to better understand the 
progression of the tumor phenotype seen in human cervical 
carcinoma. HPV-16 or 18 infection alone is not sufficient to 
transform primary cells, other factors are thought to play a 
role (Broker and Botchan, 1986, Mccance, 1986). Our data 
suggest that immortalization of primary cells is quite 
difficult and may be facilitated by other factors or genetic 
lesions. In R-30 cells a chromosomal translocation was 
detected between chromosomes 8 and 18. These cells also had 
elevated levels of c-myc compared to other low passage 
gingival cells (N-16 and C-1). It is tempting to suggest 
these alterations in R-30 cells allowed for more efficient 
immortalization by HZIP-16. 
When HSV-2 mtr III sequences were present, a clear 
difference in phenotype was demonstrated between HPV-16 
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immortalized and HPV-16/HSV-2 transformed cell lines. The 
presence of both viral DNAs clearly enhanced the 
transformation phenotype of primary human cells in saturation 
density values, anchorage-independent growth and aneuploidy 
when compared to cell lines with HPV-16 DNA alone. Based on 
these observations, HPV-16/HSV-2 fibroblast cell lines were 
more transformed than HZIP-16 immortalized cells. The 
inability to form tumors in nude mice may suggest the cells 
were not completely transformed or the human cells were merely 
rejected by the mouse. It is also possible that additional 
alterations may be necessary for complete transformation of 
fibroblast cell lines. For example, tobacco use induces 
progression to invasive carcinoma in women with low grade 
cervical intraepithelial neoplasia (Vessey, 1986, Trevathan et 
al., 1983). 
Although, a synergistic relationship is seen with HPV-16 
and HSV-2 in fibroblast cell lines, another model system was 
employed to verify this synergy. HPVs are epitheliotrophic 
viruses (reviewed in Broker and Botchan, 1986). Furthermore, 
HSV-2 replicates in epithelial cells in vivo (Roizman, 1985). 
Thus, it would be advantageous to examine HPV/HSV-2 
interactions in cells of epithelial origin. To achieve this 
goal, genital keratinocytes were employed. 
CHARACTERIZATION OF HUMAN KERATINOCYTE CELL LINES. 
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To study interactions between HSV-2 and HPV-16/18 in 
their natural host cell, human epithelial cells were employed. 
Keratinocytes are differentiating epidermal cells and thus 
these cells were utilized. Primary genital keratinocytes were 
immortalized with plasmids containing HPV-16 (FEPL) or HPV-18 
(FEA) DNA seq~ences. For analysis of keratinocyte cell lines, 
HSV-2 mtr III DNA sequences were transfected into previously 
HPV immortalized keratinocytes rather than cotransfected with 
HPV DNA sequences. Thus, cells were already expressing HPV 
genes and expression was regulated by the LCR of the HPV 
genome. Two cell lines were used as parental cells, HPV-16 
immortalized (FEPL) and HPV-18 immortalized (FEA) cells. 
Transfection analysis demonstrated that no single region of 
HSV-2 mtr III was more efficient for transforming either FEPL 
or FEA cells (Table 6) suggesting the minimal transforming 
fragment, 486 TF, was sufficient for morphological 
transformation of human HPV immortalized cells. 
Growth characteristics of keratinocyte cell lines were 
assessed. Saturation density analysis indicated FEPL or FEA 
cells transformed by mtr III DNA sequences contained two times 
the number of cells after one week in culture than their 
immortalized counterpart (Table 7) • However, · cell lines 
differed in their ability to grow in soft agar. Neither FEA 
cells nor transformed derivatives were able to grow in 0.3% 
agar. In contrast, FEPL transformed cells grew with high 
efficiency in soft agar (Table 7). Immortalized FEPL cells 
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also grew in 0.3% agar, however not with the efficiency of 
their transformed counterpart. The inability of FEA cells to 
exhibit anchorage independent growth suggested these cells may 
not be fully transformed compared to FEPL transformed 
derivatives. 
Many studies have established a role for the activation 
of oncogenes such as c-myc and the inactivation of tumor 
suppressor genes, p53, in carcinomas (Riou et al., 1987, Crook 
et al., 1990, Schaffner et al., 1991). We wanted to examine 
if these genes were altered in the keratinocyte cell lines. 
Southern blot analysis of DNA from transformed cell lines 
hybridized to two c-myc probes showed no alterations in this 
gene when compared to immortalized keratinocytes (Figures 22, 
23). Furthermore, no detectable alterations of the hp53 gene 
were observed in transformed cells (Figures 24, 25). This 
data suggested that alterations of the hp53 or c-myc genes 
were not required for transformation of keratinocyte cell 
lines. 
Analysis of HPV DNA organization of transf armed cell 
lines was performed to determine if rearrangments of the HPV 
DNA occurred. FEPL cells contained 3. 4 kb of the HPV-16 
genome which encompasses the LCR, ORFs E6, E7 and subregions 
of El and Ll (Kaur et al., 1989). Integration of HPV-16 DNA 
sequences into the cellular genome seldom disrupts the LCR, E6 
and E7 ORFs (Matsukura et al., 1986, Pater and Pater, 1985, 
Seedorf et al., 1987) since these are necessary for 
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immortalization. In cells obtained from cervical carcinomas 
the integration site of HPV DNA is frequently within E2 (Durst 
et al., 1986, Matsukura et al., 1986, Pater and Pater, 1985). 
The integration event usually disrupts E2. Since FEPL cells 
contain just the HPV-16 sequences which are required for 
immortalization, it was not surprising that rearrangments of 
HPV DNA were not detected in the HSV-2 transformed cells. 
FEA transformed derivatives were also analyzed to examine 
HPV-18 DNA organization. FEA cells contain the entire genome 
of HPV-18, 7.9 kb DNA (Kaur and McDougall, 1988). When high 
molecular weight DNA was hybridized with a probe spanning the 
entire 7.9 kb genome of HPV-18, rearrangments of HPV DNA in 
. cells transformed by HSV-2 was detected when compared to 
immortalized cells (Figures 17, 18) • However, no changes were 
detected when DNA was probed with a HPV-18 probe spanning the 
LCR, E6 and E7 regions (Figure 19). This was predictable 
since expression of E6 and E7 is required for maintaining an 
immortalized state. Specific recombination between HSV-2 and 
HPV-18 may not occur since rearrangments of HPV-18 DNA also 
occurred in cell line A-ras (Figure 18, lane H), FEA cells 
transfected with H-ras. Rearrangements in HPV-18 DNA 
sequences in FEA transformed cell lines may suggest that the 
presence of the entire genome of HPV-18 provides a greater 
region available for recombination between the two DNAs in 
contrast to FEPL cells containing only 3.4 kb HPV-16 DNA. 
The retention of HSV-2 DNA sequences in transformed cells 
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is inconsistent (reviewed by MacNab, 1987). However evidence 
has demonstrated a correlation between HSV-2 infection and 
cervical carcinoma (DiLuca et al., 1989, Hildesheim et al., 
1991). Thus, keratinocyte cell lines were examined to detect 
the retention of HSV-2 sequences. Southern blot analysis 
failed to detect HSV-2 mtr III sequences. When PCR analysis 
was utilized to detect HSV-2 sequences in transformed cells, 
not all of the cell lines contained HSV-2 DNA sequences 
(Figure 21). In fact, analysis of FEPL and FEA transformed 
derivatives indicated HSV-2 retention in only 3/5 HPV-18/HSV-2 
cell lines and 0/5 HPV-16/HSV-2 cell lines. since all cell 
lines do not retain HSV-2 DNA, retention is not required for 
maintenence of the transformed phenotype. Conversely, only 
small portions of HSV-2 DNA are retained in transformed cell 
since HSV-2 is known to excise itself and portions of the 
cellular genome (Jariwalla et al., 1986). This random nature 
of HSV-2 retention in keratinocyte cell lines seems to confirm 
the hypothesis that HSV-2 DNA sequences are required for the 
initiation of transformation but not the maintenance of the 
transformed state (Skinner, 1976, Galloway and McDougall, 
1983). 
behaved 
though, 
After HSV-2 transfection, transformed cell lines 
distinctly from immortalized counterparts, even 
HSV-2 DNA was not detected in all transformed 
derivatives. 
The tumorigenic potential of FEA and FEPL cell lines was 
examined by injecting respective cell lines subcutaneously 
into nude mice. 
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FEA cells, immortalized as well as 
transformed, were unable to produce any tumors. Tumor-like 
lesions were not detected even with FEA cells transfected with 
H-ras. In contrast, all FEPL transformed derivatives were 
able to form abnormal epithelial lesions (Table 8) • FEPL 
cells transfected with H-ras were not invasive as Matlashewski 
et al., (1987) had demonstrated previously with rodent cells. 
This may suggest that human cells are more refractile to 
tumorigenic conversion when compared to rodent cells. Tumor-
like lesions were present when HSV-2 transformed FEPL cells 
were injected into nu/,ny mice but not with FEPL cells. It can 
be implied that alterations have occurred in transformed FEPL 
cells and the initial stages of the transformed phenotype are 
being exhibited. 
When the tumor-like lesions were examined by histological 
methods, they were identified as benign cysts. If cells from 
an invasive cervical carcinoma (Hela) were injected into nu/nu 
mice, large metastatic tumors developed. The size of the FEPL 
epithelial cyst was quite small, 3-5 mm in size (Figure 27), 
whereas, the Hela tumor grew to more than 20 times this size 
(Figure 29). Both epithelial lesions and Hela tumors were 
solid masses and thus difficult to dissect. small nodules 
were also detected in immortalized FEPL cells 1-2 weeks post 
injection. However, these small nodules regressed. In 
contrast, when FEPL transformed cells were injected into nu/nu 
mice, tumor-like lesions appeared 2-3 weeks post injection and 
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remained up to 8 weeks with slow continous growth. When Hela 
cells were injected into mice, 1 week post injection, several 
tumors developed near the site of injection which grew 
rapidly. Histological analysis demonstrated differences among 
lesions. With the Hela tumor, numerous multinucleated cells, 
abnormal mitotic phases were visible along with necrotic cells 
near the tumor (Figure 28) indicative of anaplastic carcinoma. 
In contrast, the tumor-like lesion induced by HSV-2 
transformed cells were a keratinized cyst. The cyst contained 
actively growing cells which enlarged the lesion with time. 
These results demonstrated that FEPL cells transformed by HSV-
2 fragments derived from mtr III were able to form small 
benign tumors or cysts in nu/DY mice. 
The mechanism by which a cell progresses to the malignant 
phenotype after HPV-16 infection in vivo is not known. The 
presence of HPV-16 or HPV-18 alone is not sufficient for 
tumorigenesis (reviewed in Broker and Botchan, 1986). 
Additional cofactors, environmental or viral, may play a 
crucial role in tumor progression events. Since HSV-2 is 
transmitted sexually similar to HPVs, infects the same cells 
as HPVs, and can induce morphological transformation, 
progression may be mediated by this virus (zur Hausen, 1983). 
studies assessing a posssible synergy between HSV-2 and high-
risk HPV infections in the pathology of cervical carcinoma 
have looked for the presence of both viral DNAs in tumor 
tissue. Molecular analysis of HPV-16 and HSV-2 demonstrated 
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that 30% of cervical cancer tissues had homology to HSV-2 mtr 
II and mtr III sequences (DiLuca et al., 1989) • 
Seroepidemiological studies have demonstrated an etiologic 
role for HSV-2 in the development of cervical cancer where 
women with cervical cancer have higher levels of HSV-2 
antibodies compared to controls (Kaufman and Adam, 1986). 
Women that are HSV-2 seropositive and infected with HPV-16/18 
have a 60% increased risk of cervical cancer compared to 
seronegative women infected with HPV-16/18 (Hildesheim et al., 
1991). These studies provide further evidence to the role 
that HSV-2 plays in conjunction with high-risk HPVs, in 
cervical carcinoma. 
In our analysis, we have demonstrated the synergistic 
role played by HSV-2 and HPV-16/18 in the morphological 
transformation of primary human cells. Characterization of 
human cell lines immortalized by HPV-16/18 have a distinct 
phenotype compared to cells transformed by HPV-16/18 and HSV-2 
DNA sequences. The development of tumor-like lesions by 
transformed HPV-16/HSV-2 keratinocytes and not by immortalized 
HPV-16 cells suggests transfection of HSV-2 sequences may have 
altered these cells and led to enhanced invasive properties. 
HSV-2 is known to induce stable heritable changes in the cell 
without the need for viral replication or gene expression 
(Clarke and Clements, 1991). Thus, in FEPL cells which have 
been already altered by immortalization, the mutagenic 
abilities of HSV-2 could induce alterations in cellular DNA 
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and subsequently lead to the transformed phenotype. 
However, FEA cells containing the entire genome of HPV-18 
did not produce any lesions in mice even though J/5 cell lines 
retained HSV-2 DNA sequences and transformed cell lines had 
HPV-18 DNA rearranged. It may be speculated that several 
factors have a role in the inability of these lesions to 
produce tumors. FEA cells with the complete HPV-18 genome can 
express the E2 protein which acts as a transacti vator or 
repressor of HPV gene expression (Phelps and Howley, 1987, 
Cripe et al., 1987). Full-length E2 binds to Spl sites to 
transactivate transcription whereas a truncated E2 will 
repress transcription (Li et al., 1991, Cripe et al., 1987). 
Thus, if rearrangments within the HPV-18 genome altered the E2 
gene, truncated E2 proteins may act not only on the HPV-18 LCR 
but also on the promoters of HSV-2 mtr III sequences (Jones, 
1989) to down regulate transcription. 
HPV-16/18 DNAs are associated with the majority of 
cervical carcinomas, the viral DNA can be detected in at least 
85% of cervical carcinoma biopsies (Broker and Botchan, 1986). 
Of these, HPV-16 accounts for approximately 60% of HPV 
positive cervical carcinomas while HPV-18 accounts for 
approximately 10-15% (Villa and Schlegel, 1991). The reason 
for the prevelance of HPV-16 in cervical carcinoma and not 
HPV-18 is not known. No significant differences have been 
found between E6 and E7 proteins of types 16 and 18, nor was 
there any major disparity in the LCRs of both viruses (Villa 
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and Schlegel, 1991). It may be that HSV-2 interacts with HPV-
16 to produce a malignant phenotype but cannot carry out the 
same interactions with HPV-18. 
In our analysis, the characterization of keratinocyte 
cell lines imply that HSV-2 can interact with HPV-16 to 
produce cells with a transformed phenotype but it is not able 
to do so with HPV-18. Data also suggests that HSV-2 can act 
as a cofactor with HPV-16 to transform primary human cells. 
Premalignant papillomavirus lesions in a number of animal 
models progress to malignancy after interacting with other 
known mutagens (Jarrett et al., 1980, Rous and Kidd, 1938, 
Orth et al., 1978). HSV-2, with its ability to act as a 
biological mutagen, is a biologically relevant cofactor in the 
development of genital cancer. 
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